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                                     Abstract 
 
CRISPR-Cas9 and Genetic Modifications:  
The Science, the Ethical Questions and Theological Reflection 
Camillia Musano 
 
Genetic engineering has been a subject of interest to ethicists and theologians specifically 
with genetic modifications using CRISPR-Cas9. The way CRISPR functions is that it can cut a 
specific DNA sequence and then it can silence or insert and delete genes. This scientific method 
can help treat or prevent diseases by removing the DNA sequences that causes them. Furthermore, 
CRISPR could also be used to enhance genetic traits through this kind of gene editing. The ethics 
surrounding CRISPR has been a growing concern, specifically whether someone has the right to 
intervene in a person’s DNA without their consent, such as in utero. In addition, there have also 
been concerns on how genetic modifications affect our autonomy, moral agency, actions and 
society as a whole. Theological reflection on genetic modifications asks deeper questions. We 
begin to see how genetic modification can affect the foundations of Christianity in healthcare. 
Moreover, theology explores the question of whether or not it is moral for a human to play God 
and what a future might be like with genetically modified individuals. This leads us to reflect on 
what it means to be human once our bodies are changed in this way. Genetic modifications provoke 
differing views among many people and this thesis will explore the different perspectives in order 
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The goal of this thesis is an exploration of the ethical and theological implications of 
genetic modifications and CRISPR-Cas9. The following is a brief overview of what each of the 
three chapters tackles. It will first start by introducing the science behind genetic modifications 
and CRISPR-Cas9 to understand what this technology is and how it functions. This will lead, in 
the second chapter, to the discussion of the ethical implications surrounding genetic modifications 
that raise questions about autonomy, moral agency, and parental intervention. The last chapter of 
the thesis will cover theological arguments regarding genetic modifications. Such arguments 
include the topics of Christian foundations, playing God, eschatology, and the question of human 
nature. These various topics will bring to light the very essence of what is involved in discussions 
around genetic modifications.  
CRISPR-Cas9 is slowly making a name for itself in the world with new progress every day 
for treatment options. CRISPR stands for “clustered regularly-interspaced short palindromic 
repeats” which consists of short repetitions of DNA sequences followed by short non-coding DNA 
that arose from the discovery of a bacterial virus or plasmid.1 In addition, the cas (CRISPR-
associated) genes code for the cutting enzymes that cut or unwind DNA in an organism.2 How this 
system works is that CRISPR stores and protects DNA sequences from invading viruses or 
plasmid, so when the same type invades again the system will recognize it using a copied RNA 
sequence that directs a cas cutting enzyme to cut the DNA.3 What CRISPR does is that it targets a 
specific DNA sequence and modifies that DNA. Scientists have been doing extensive work since 
2013 to ensure that it is used safely on human beings.4 CRISPR-Cas9 can be engineered for 
different functions such as introducing DNA into the germline of any organism, modifying somatic 
genes by genome editing and modifying different DNA factors to target and activate or silence 
specific genes.5 However, this gene editing tool can also cause unintended mutations. Unintended 
mutations in the genome can delay the use of CRISPR-Cas9, specifically with gene therapy.6 In 
addition, CRISPR-Cas9 could cut unintended DNA sequences that could cause cells to die or 
 
1 E. Rodriguez, “Ethical Issues in Genome Editing using CRISPR/Cas9 System,” Journal of Clinical 
Research and Bioethics 07, no. 02 (March 24, 2016): 1, https://doi.org/10.4172/2155-9627.1000266.  
2 Rodriguez, “Ethical Issues in Genome Editing using CRISPR/Cas9 System,” 1, paraphrased from Ruud. 
Jansen et al., “Identification of Genes That Are Associated with DNA Repeats in Prokaryotes,” Molecular 
Microbiology 43, no. 6 (April 25, 2002): 1565-75, https://doi.org/10.1046/j.1365-2958.2002.02839.x.  
3 Rodriguez, 1. 
4 Rodriguez, 1, paraphrased from Alfred Chin, “CRISPR-Cas9 Therapeutics: A Technology Overview,” 
Science Innovation Union, The Science Innovation Union, September 9, 2015, http://science-
union.org/articlelist/2015/9/9/crispr-cas9-therapeutics-a-technology-overview.  
5 Rodriguez, 1; paraphrased from Matthew H. Larson, et al., “CRISPR Interference (CRISPRi) for Sequence-
Specific Control of Gene Expression” Nature Protocols 8, no. 11 (October 17, 2013): 2180-96, 
https://doi.org/10.1038/nprot.2013.132.  
6 Puping Liang,et al. "CRISPR/Cas9-Mediated Gene Editing in Human Tripronuclear Zygotes," Protein & 
Cell 6, no. 5 (April 18, 2015): 364, https://doi.org/10.1007/s13238-015-0153-5, paraphrased from Patrick D. Hsu, Eric 
S. Lander, and Feng Zheng, “Development and Applications of CRISPR-Cas9 for Genome Engineering,” Cell 157, 
no.6 (June 5, 2014): 1262-78, https://doi.org/10.1016/j.cell.2014.05.010 ; Prashant Mali, Kevin M. Esvelt, and George 
M. Church, “Cas9 as A Versatile Tool for Engineering Biology,” Nature Methods 10, no. 10 (September 27, 2013): 
957-63, https://doi.org/10.1038/nmeth.2649 ; Jeffry D. Sander and J. Keith Joung, “CRISPR-Cas Systems for Editing, 




transform into something that might cause problems to the person in question.7 Scientists have 
been trying to reduce these kinds of off-target mutations, but more improvement through testing is 
needed. This is especially so for therapeutic interventions, which are very precise.8  
It is important that people are made aware of the ethical implications that are associated 
with genetic modifications and CRISPR-Cas9. This area of genetic engineering is relatively new, 
and education about it is important. The general public may only know of it because of the mass 
media and so may only know of its name and have a surface understanding of what it is and can 
do. A deeper understanding is required and the general public should be informed about different 
ethical concepts relevant to genetic modification. These include autonomy, moral agency, parental 
intervention in a child’s genetic makeup, and the effects of social classes. Some questions that arise 
are whether it is right for a parent to intervene in their child’s genetic makeup or is someone still 
able to be autonomous after being genetically modified. There are also questions linked to the 
responsibility of actions after being modified. These discussions have been taken up by different 
thinkers such as Jürgen Habermas, John Harris, and Michael Sandel. Debate on the ethics 
surrounding gene editing can play a role in educating the public on its positive and negative 
aspects. This can be valuable for people especially if they want to partake in a discussion with this 
newfound knowledge and voice their opinion on the topic. This becomes especially needed for 
legislative and regulating purposes. Moreover, adding theology to the discussion becomes 
pertinent as well.  
Theology becomes important for people who want to have a deeper understanding of 
themselves. When using the theological method of foundations, the individual can understand how 
genetic modifications can coincide with the foundations of Christianity in healthcare. One doctor 
in particular, Dr. Daniel Sulmasy, demonstrates the symbolism and the values that Christianity 
offers in the context of healthcare. This can especially be seen with relationships that are formed 
between doctors and patients. Theology also allows individuals to ask existential questions in 
relation to genetic modifications and CRISPR-Cas9. It can help go beyond the surface to 
understand why human beings might undertake this role of trying to “play God” along with its 
positive and negative aspects. Furthermore, this ability to reflect deeply on their own experience 
in asking these existential questions allows them to understand the essence of what it means to be 
human in our current society. This can also lead to comparisons from the past and what the 
possibilities may be in the future. With that being said, we see why ethics and theology in relation 
to genetic modifications becomes very important. Theological and ethical questions are important 
because they allow people to go beyond their horizons by learning something that is completely 
new and challenging.  
 
7 Rodriguez, “Ethical Issues in Genome Editing using CRISPR/Cas9 System,” 2, paraphrased from Yanfang 
Fu et al., “High Frequency Off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells” Nature 
Biotechnology 31, no. 9 (June 23rd, 2013): 822-26, https://doi.org/10.1038/nbt.2623 ; Xiao-Hui Zhang et al., “Off-
Target Effects in CRISPR/Cas9-Mediated Genome Engineering,” Molecular Therapy Nucleic Acids 4, no. 11(January 
1, 2015): e264, https://doi.org/10.1038/mtna.2015.37.  
8 Rodriguez, 2, paraphrased from L. Cong et al., “Multiplex Genome Engineering Using CRISPR/Cas 
Systems,” Science 339, no. 6121 (January 3, 2013): 819-23, https://doi.org/10.1126/science.1231143 ; Yuanwu Ma, 
Lianfeng Zhang, and Xingxu Huang, “Genome Modification by CRISPR/Cas9,” FEBS Journal 281, no. 23 
(November 7, 2014): 5186-93, https://doi.org/10.1111/febs.13110 ; Patrick D Hsu et al., “DNA Targeting Specificity 





CRISPR-Cas9 and genetic modifications are a very recent topic in the world of genetic 
engineering. Due to this, there were some challenges in relation to the research that was done for 
this thesis. In terms of ethical research, there was quite a lot of literature on this topic since genetic 
engineering in general has been frequently discussed in the world of bioethics. Genetic 
modification has received much attention among ethicists in the last ten years. Ethical analyses 
allow us to weigh the benefit and risks of certain topics to see if it can benefit humanity.  
In terms of theological research, this is where challenges can occur due to the lack of 
abundant resources. There are recent theological resources, for example, papal and church 
documents discussing gene editing and there are some but not many theologians who have recently 
written on this topic. Most literature found was between twelve to twenty years old. While this 
may seem recent, the technology advances every day. The values and message that this literature 
advocates is definitely still relevant today, but more theological analyses are needed since it has 
become a ‘hot topic’ in science in most recent years. The input of papal and church documents is 
valuable, but it would also be interesting to see other theological perspectives. Theological 
reflection on genetic modification is significant since it lets all of society relate to it and not just 
those who understand the science. When people read theological literature, it enlightens their 
capacity to go within themselves to find a deeper meaning of what genetic modification really 
means to them. Yet, with this scientific technology becoming more popular, there is no doubt that 
more theological literature will appear in the years to come. 
As stated previously, not every individual is familiar with the CRISPR-Cas9 technology. 
The thesis aims to shed light on CRISPR-Cas9 and genetic modifications. It will engage in 
arguments that are both for and against genetic modifications in order to understand both sides. 
The aim of this is to explore the different ethical and theological perspectives of genetic 
modifications to enhance knowledge on this topic.  
The ethical and theological aspects surrounding CRISPR-Cas9 and genetic modifications 
are intriguing and important to discuss. This new technology has the potential to eradicate a disease 
in a family line forever and it can also alter a person by enhancing a genetic trait. Ethical and 
theological questions/concerns emerge because of the power of the technology. This thesis will 
identify these questions and explain the concerns. Discussions around CRISPR and gene editing 
need to involve more than science. We need to consider the human being involved in this process, 
how it will affect them and what their beliefs are on it. It affects their identity as a person trying to 
grasp what this all means to them. The goal of the thesis is to begin to understand what CRISPR 










Chapter 1: The Science of Genetic Modifications and CRISPR-Cas9 
 
Introduction 
Gene editing technology has been one of the most spoken about and controversial 
technologies in genetic engineering. Genetic engineering has been a growing field over the last 
two decades especially prenatally. These new and emerging technologies, such as CRISPR-Cas9 
are presenting many challenges. CRISPR-Cas9 targets specific sections of genetic code and edits 
DNA at exact locations.9 Scientists see CRISPR as a way to help prevent illnesses, so parents may 
have healthy babies and not have them suffer from an illness all their life. In order to understand 
what CRISPR-Cas9 does, before exploring the topics of ethics (Chapter two) and theology 
(Chapter three) concerning genome editing, one must understand its scientific background  
The way CRISPR-Cas9 functions is that it can cut DNA and it can silence genes or even 
insert and delete genes. CRISPR-Cas9 is revolutionary because it could help treat diseases by 
removing the genetic sequence that could cause the disease. However, CRISPR-Cas9 could also 
affect off-target sites, which are genetic sequences that are not targeted by CRISPR-Cas9. This 
could lead to side effects or even mutations that may cause serious illnesses. More research is 
needed to improve the efficacy of CRISPR but as of recently there are some biological tools that 
scientists have produced in order to detect these off-target sites. Some of these methods are not as 
reliable because they are still in the development stage. There is also another technique to help 
eliminate diseases and those are mitochondrial replacement techniques which are somewhat safer 
than CRISPR-Cas9 since these changes in mitochondrial replacement techniques are passed down 
uniparentally and not from both parents. CRISPR-Cas9 should be understood scientifically first 
before one can tackle the concerns it raises. 
The chapter is divided into five sections. First, CRISPR-Cas9 will be defined following by 
an explanation of its different functions. This leads to a third section that explores the problem of 
unwanted mutations in the genome and different methods of dealing with these problems. 
Following this will be a consideration of the overlap and differences between genetic enhancement 
and genetic therapy. The final section investigates an alternative to gene editing, that is, 
mitochondrial replacement techniques. 
  
1) What is CRISPR-Cas9? 
Genome editing is a technique used to effectively modify DNA within a cell at precise 
locations on the DNA strand.10 Enzymes called ‘nucleases’ cut specific DNA sequences.11 
Enzymes are produced by the body to help speed up a biochemical reaction. Genome editing can 
add, remove or modify DNA in a gene and edit the DNA characteristics of a cell or an organism.12 
CRISPR stands for “clustered regularly-interspaced short palindromic repeats” which are short 
 
9“Questions and Answers about CRISPR,” Broad Institute, Broad Institute, accessed September 18th, 2019, 
https://www.broadinstitute.org/what-broad/areas-focus/project-spotlight/questions-and-answers-about-crispr.  
10 “What Is Genome Editing?,” yourgenome, The Public Engagement team at the Wellcome Genome 
Campus, last modified August 23, 2017, https://www.yourgenome.org/facts/what-is-genome-editing.  
11 “What is Genome Editing?” 
12 “What is Genome Editing?” 
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repetitions of DNA sequences followed by short non-coding DNA that came from a bacterial virus 
or plasmid.13  
In addition, there are proteins that are associated with CRISPR, which are the “cas” 
(CRISPR-associated) genes that code for nuclease enzymes that are linked to CRISPR since they 
function to cut the DNA.14 There are three types of CRISPR mechanisms but type II is the most 
studied.15 The type II mechanism is described as follows: invading DNA from viruses or small 
plasmids are cut into small pieces and are fused at a fixed position on the CRISPR chromosome.16 
The fused pieces at the fixed position on the CRISPR DNA are copied, and the copies are processed 
to make small RNA which are called cr-RNA (CRISPR-RNA).17 The cr-RNA are then used to 
guide the nuclease enzymes, which target invading DNA based on DNA sequence 
complementarity/similarity.18 Complementarity is when the RNA and DNA strands are aligned to 
show that they have similar base pairs in common. Moreover, only one Cas protein, Cas9, has been 
shown to be a key element in some CRISPR mechanisms such as type II.19 Furthermore, type II is 
unique because it only requires Cas9 for gene silencing and for genome editing.20 
 This CRISPR process is not the mechanism used on humans, rather, a simpler process 
which is the RNA-programmable method is used to help with genome editing. It can be used for 
insertion or deletion of genes.21 The type II mechanism states that Cas9 must be paired with crRNA 
and trans-activating crRNA(tracrRNA).22 This will help disrupt a gene in the genome editing 
process so that a single-guide RNA (sgRNA) which is the combination of the crRNA and the 
tracrRNA directs Cas9 to a specific location on the genome.23 Then, the sgRNA (crRNA + 
tracrRNA) interacts with the Cas9 protein so that it can cut the target DNA.24 Next, this protein 
complex (sgRNA + Cas9) will cut the target-specific double-stranded DNA and the cutting site 
will be repaired by joining the two ends of the DNA strands. This can be an erroneous process 
because foreign DNA could be inserted or deleted which then disrupts the function of the gene.25 
In sum, there are different mechanisms on how CRISPR works but the main idea is that it uses an 
RNA that is paired to Cas9 to cut the target DNA and replace it at a specific location.  
2) Functions of CRISPR 
 
13Rodriguez, “Ethical Issues in Genome Editing using CRISPR/Cas9 System,” 1. 
14 Rodriguez, 1, paraphrased from Jansen et al., “Identification of Genes That Are Associated with DNA 
Repeats in Prokaryotes,” 1565-75. 
15 “CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology,” New England Biolabs: 
Reagents for the Life Sciences Industry, New England Biolabs, accessed January 26, 2019, 
https://international.neb.com/tools-and-resources/feature-articles/crispr-cas9-and-targeted-genome-editing-a-new-
era-in-molecular-biology.  
16 “CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology.” 
17 “CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology.” 
18 “CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology.” 
19 “CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology.” 
20 “CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology.” 
21 “Introduction to the CRISPR/Cas9 System,” Takara Bio-Home, Takara Bio USA, Inc., accessed January 
29, 2019, https://www.takarabio.com/learning-centers/gene-function/gene-editing/gene-editing-tools-and-
information/introduction-to-the-crispr/cas9-system.  
22 “CRISPR/Cas9 & Targeted Genome Editing: New Era in Molecular Biology.” 
23 “Introduction to the CRISPR/Cas9 system.” 
24 “Introduction to the CRISPR/Cas9 system.” 
25 “Introduction to the CRISPR/Cas9 system.” 
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CRISPR-Cas9 can be engineered to do whatever genetic functions a person desires. It can 
introduce DNA in the germline, which are the heritable genes of any organism, and modify somatic 
genes, which are the non-heritable genes, by genome editing.26 Therefore, CRISPR-Cas9 can 
genetically edit the non-heritable genes of living organisms such as humans and animals. In 
addition, CRISPR-Cas9 has been modified to adjust specific transcription factors, which are copies 
of DNA that can activate or silence specific genes.27 With this, CRISPR-Cas9 can be used to target 
and activate the genes a person wants and silence the ones that are deemed unnecessary. 
Furthermore, CRISPR-Cas9 can be used to make animal models for research to imitate diseases 
or to study the disease’s development by mutating or silencing genes associated to that disease.28 
There has already been testing on animals to see how CRISPR-Cas9 works when it comes to 
genetic diseases, but human trials will need to be regulated thoroughly because of the side effects 
CRISPR may cause due to off-target effects. For example, a mouse was used to test the harmful 
effects of mutations found in cancer by inputting the loss-of-function mutations in tumor 
suppressor genes or gaining-of-function in proto-oncogenes.29 In this example, it seems that these 
scientists were exploring the functions that CRISPR-Cas9 can do. It could silence a gene that is 
used to help suppress tumors in order to observe the effects that could happen to the mouse. This 
could lead to promoting the function in proto-oncogenes, which can then lead to cancer. 
Moreover, “genome editing has the potential to cure diseases by disrupting endogenous 
disease-causing genes, correcting disease causing mutations or inserting new genes with protective 
functions.”30 It can also correct gene mutations that caused the disease and insert new genes that 
can protect the body from harm. If this is inserted in the germline then future generations will not 
carry this disease. In addition, disrupting endogenous disease causing genes can benefit the 
biomedicine industry because it can help develop tissue-based treatments for cancer and other 
diseases.31 For instance, CRISPR-Cas9 can target the HIV provirus.32 A provirus can be integrated 
in the genetic material of a host cell where it then replicates the host and spreads from one cell 
generation to the next.33 This will then help with the removal of the integrated HIV viral genome 
or prevent the entry of the virus cells.34 Thus, CRISPR-Cas9 can prevent this disease from ever 
trying to form in the body so the human being wouldn’t have to take any precautionary measures 
in their life. Furthermore, “modifying the immune system to attack HIV has been gaining attraction 
 
26 Rodriguez, “Ethical Issues in Genome Editing using CRISPR/Cas9 System,” 1. 
27 Rodriguez, 1, paraphrased from Larson et al., “CRISPR Interference (CRISPRi) for Sequence-Specific 
Control of Gene Expression,” 2180-96. 
28 Rodriguez, 1. 
29 Rodriguez, 1-2, paraphrased from Alfred Chin, “CRISPR-Cas9 Therapeutics: A Technology Overview.”  
30 Rodriguez, 2. 
31 Rodriguez, 2, paraphrased from Devashish Rath et al., “The CRISPR-Cas Immune System: Biology, 
Mechanisms and Applications,” Biochimie 117 (October 2015): 119-28, https://doi.org/10.1016/j.biochi.2015.03.025.  
32 Rodriguez, 2, paraphrased from Sheena Saayman et al., “The Therapeutic Application of CRISPR/Cas9 
Technologies for HIV,” Expert Opinion on Biological Therapy 15, no. 6 (April 12, 2015): 819-30, 
https://doi.org/10.1517/14712598.2015.1036736.  
33 “Provirus,” Merriam-Webster, Merriam-Webster, Incorporated, accessed May 11, 2020, 
https://www.merriam-webster.com/dictionary/provirus.  
34 Rodriguez, “Ethical Issues in Genome Editing using CRISPR/Cas9 System,” 2, paraphrased from Saayman 
et al., “The Therapeutic Application of CRISPR/Cas9 Technologies for HIV,” 819-30. 
7 
 
as a promising therapeutic use of genome editing.”35 This means that this method could also have 
the potential to be used to treat other diseases once more positive outcomes are achieved.  
According to scientific research, the outcomes of cell-based/gene therapies could be very 
advantageous since these therapies can remove, manipulate, expand and reintroduce these cells 
into the patient in order to enhance the therapeutic effect they want.36 However, with “other 
diseases such as solid tumor cancers or those that effect tissues and organs, CRISPR-Cas9 is 
unlikely to be effective given the present state of the technology.”37 For instance, there is research 
being conducted where CRISPR-Cas9 is being used to edit the CFTR gene in cystic fibrosis and 
dystrophin in Duchenne muscular dystrophy.38 However, there are still some hindrances because 
even though there were some technological advancements, the research is still just beginning and 
this gene editing technology runs into some challenges in relation to the delivery methods of the 
transfer of genes that were first seen in the 1990s.39  
Even though CRISPR-Cas9 and other cell-based therapies have been shown to be effective, 
it does not work on every disease. More research must be done to determine if it will be effective 
on other diseases as well. Diseases that affect tissues and organs or cancers are still not suitable 
for CRISPR-Cas9 because as mentioned previously there could be off-target mutations carrying 
the possibility of health side effects for the human and offspring. In addition, since cancer remains 
very difficult to cure, there still needs to be extensive research done with CRISPR in order for it 
to work. Cancer divides abnormal cells uncontrollably, which is still difficult to cure, and the off-
target effects could negatively impact the cancer patient by causing more pain and discomfort then 
they already have. 
In addition, with CRISPR-Cas9 the modification of DNA can occur in human embryos. In 
2015, a scientist from China published a paper in the journal, Protein and Cell, and stated that 
modifying DNA with abnormal human embryos rejects the use of in vitro fertilization.40 He also 
found there to be “limited success in correcting a mutation that causes the disease of beta-
thalassemia using CRISPR-Cas9 [since] [t]he experiments resulted in changing only some of the 
genes and, had off-target effects on other genes.”41 These off-target effects could severely impact 
the human being in question. CRISPR-Cas9 is not ready to be used for medical purposes especially 
 
35 Adam P. Cribbs and Sumeth M W Perera, “Science and Bioethics of CRISPR-Cas9 Gene Editing: An 
Analysis Towards Separating Facts and Fiction,” Yale Journal of Biology and Medicine 90, no.4 (December 19, 2017) 
628, https://pubmed.ncbi.nlm.nih.gov/29259526/, quoted from Pablo Tebas et al., “Gene Editing ofCCR5in 
Autologous CD4 T Cells of Persons Infected with HIV,” New England Journal of Medicine 370, no. 10 (March 6, 
2014): 901-10, https://doi.org/10.1056/nejmoa1300662.  
36 Cribbs and Perera, “Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards 
Separating Facts and Fiction,” 628. 
37 Cribbs and Perrera, 628.  
38 Cribbs and Perrera, 628, paraphrased from Gerald Schwank et al., “Functional Repair of CFTR by 
CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients,” Cell Stem Cell 13, no. 6 (December 5, 
2013): 653-58, https://doi.org/10.1016/j.stem.2013.11.002. ; Hongmei Lisa Li et al., “Precise Correction of the 
Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-
Cas9,” Stem Cell Reports 4, no. 1 (January 13, 2015): 143-54, https://doi.org/10.1016/j.stemcr.2014.10.013.  
39 Cribbs and Perrera, 628. 
40 Rodriguez, “Ethical Issues in Genome Editing using CRISPR/Cas9 System,” 2. 
41 Rodriguez, 2; paraphrased from Puping Liang et al., “CRISPR/Cas9-Mediated Gene Editing in Human 




since it modifies all the cells in zygotes or early stage embryos, including the germline cells.42. 
Medical use on humans is not yet recommended since much improvement is required.  
CRISPR-Cas9 is already used for plants and this is something with which society is already 
familiar. Genetically altered plants, fruits and vegetables are called GMO’s or genetically modified 
organisms. Therefore, gene editing is not completely new to everyone today since we have all been 
exposed to GMOs for several years, but in the form of plants, vegetables and fruits. In brief, 
CRISPR has the potential to treat and prevent some illnesses but not all. Even with that potential, 
there is still the risk of side effects. Since this technology is constantly evolving, it is hopeful with 
scientific research that these side effects could be minimal in the future. 
 
3) Mutations  
After discussing the function and the applications of CRISPR-Cas9, it is important to 
mention the off-target mutations. Not only can these mutations affect the health of an individual 
person, if modifications are done on the human germline the effect can be passed on to future 
generations as well. CRISPR-Cas9 can also edit unintended DNA sequences when trying to make 
cuts to the target sequence. This can cause mutations in the genome and result in cell death or 
transformation.43 These are what we refer to as off-target sites that were affected by CRISPR-Cas9. 
The cell death or transformation caused by these unintended mutations could impact the 
individual’s health and physical condition as well. Scientists are trying to reduce off-target 
mutations, but further improvement is needed if CRISPR-Cas9 is expected to be used for treatment 
purposes.44  
Moreover, therapeutic interventions in somatic cells are considered acceptable since it 
offers more benefits and there is informed consent.45 However, therapeutic interventions done on 
the germline are still considered unacceptable since it can produce mutations and side effects, and 
these unpredictable changes could be passed down to future generations.46  
In addition, there were more of off-target effects found in human cells compared to mice 
and zebrafish.47 Therefore, it seems that these off-target effects are graver for humans. However, 
even though both mice and humans are mammals, the results will not be the same and the research 
findings are questionable as a result. Furthermore, “some of the potential side effects transmitted 
to future offspring may not be observed until several subsequent generations.”48 This can be a 
serious issue for future generations, it may not affect the person who got genetically modified but 
it could affect their offspring in the long run. These side effects could appear out of nowhere on 
 
42 Rodriguez, 2. 
43 Rodriguez, 2, paraphrased from Fu et al., “High-Frequency off-Target Mutagenesis Induced by CRISPR-
Cas Nucleases in Human Cells,” 822-26; Zhang et al., “Off-Target Effects in CRISPR/Cas9-Mediated Genome 
Engineering,” e264.  
44 Rodriguez, 2, paraphrased from Cong et al., “Multiplex Genome Engineering Using CRISPR/Cas 
Systems,” 819-23; Ma, Zhang, and Huang, “Genome Modification by CRISPR/Cas9,” 5186-93; Hsu et al., “DNA 
Targeting Specificity of RNA-Guided Cas9 Nucleases,” 827-32.  
45 Rodriguez, 3. 
46 Rodriguez, 3.  
47 Rodriguez, 2. 
48 Cribbs and Perera, “Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards 
Separating Facts and Fiction,” 630. 
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future offspring and they would not even know because they never consented to these genetic 
modifications.  
Moving on, CRISPR-Cas9 seems to be highly specific when it comes to targeting DNA, 
but the question is how are off-target sites affected? The crRNA and tracrRNA come together to 
form the sgRNA and this will be similar to the target DNA sequence and a sequence called the 
protospacer adjacent motif (PAM).49 Even though Cas9’s DNA targeting specificity is supposed to 
be pretty accurate because of the sgRNA and PAM, off-target activity could still happen on the 
DNA sequence.50 A certain part of the DNA sequence on PAM influences the binding specificity 
between Cas9 and sgRNA, this sequence is called the seed sequence.51 The seed sequence of PAM 
regulates the concentration of the Cas9-sgRNA complex which is important for Cas9 binding, 
sgRNA abundance and specificity.52  
In a CRISPR-Cas9-mediated mutagenesis in fruit flies, Ren et al. “observed a positive 
correlation between the mutagenesis efficiency and the GC content of the most proximal region to 
the PAM sequence of the sgRNAs.”53 The GC content are the nucleotides guanine and cytosine, 
which form a part of the basic structural unit of DNA/RNA, which are located at the beginning of 
the PAM sequence of the sgRNAs. The results of this experiment showed that “sgRNAs with at 
least four GCs in the sequence of the six base pairs that are the [closest] to the PAM sequence have 
a heritable mutation” which was “generated by the effective concentration of sgRNA in the 
CRISPR-Cas9 system.”54 The mutation rate was at sixty percent, which could mean that sgRNAs 
can be chosen in regards to their GC content.55 Since the seed sequence of PAM influences the 
Cas9-sgRNA binding and there is a heritable mutation in at least four GCs out of the six then this 
mutation can be passed down to future generations once the Cas9-sgRNA complex is brought to 
the target DNA. If the scientists examine the GC content carefully and conduct tests to see how 
their mutation rates vary, they could fix that in order to lower the mutations on the PAM sequence 
so Cas9 can bind to the invading DNA without any off-target mutations developing. By ruling out 
which guanines and cytosines in the sequence that cause mutations, Cas9 binding can be more 
efficient since there would be fewer mutations.  
 
49 Xiao-Hui Zhang et al., “Off-target Effects in CRISPR/Cas9-mediated Genome Engineering,” Molecular 
Therapy—Nucleic Acids 4, no.11 (November 17, 2015): 1, https://doi.org/10.1038/mtna.2015.37 , paraphrased from 
F. J. M. Mojica et al., “Short Motif Sequences Determine the Targets of the Prokaryotic CRISPR Defence System,” 
Microbiology 155, no. 3 (March 1, 2009): 733-40, https://doi.org/10.1099/mic.0.023960-0 ; Samuel H. Sternberg et 
al., “DNA Interrogation by the CRISPR RNA-Guided Endonuclease Cas9,” Nature 507, no. 7490 (January 29, 2014): 
62-67, https://doi.org/10.1038/nature13011 ; Carolin Anders et al., “Structural Basis of PAM-Dependent Target DNA 
Recognition by the Cas9 Endonuclease,” Nature 513, no. 7519 (July 27, 2014): 569-73, 
https://doi.org/10.1038/nature13579.  
50 Zhang et al., “Off-Target Effects in CRISPR/Cas9-Mediated Genome Engineering,” 1. 
51 Zhang et al., 1-2.  
52 Zhang et al., 2, paraphrased from Xuebing Wu et al., “Genome-Wide Binding of the CRISPR Endonuclease 
Cas9 in Mammalian Cells,” Nature Biotechnology 32, no. 7 (April 20, 2014): 670-76, https://doi.org/10.1038/nbt.2889 
; Tim Wang et al., “Genetic Screens in Human Cells Using the CRISPR-Cas9 System,” Science 343, no. 6166 (January 
3, 2014): 80-84, https://doi.org/10.1126/science.1246981.  
53 Zhang et al., 2, quoted from Xingjie Ren et al., “Enhanced Specificity and Efficiency of the CRISPR/Cas9 
System with Optimized SgRNA Parameters in Drosophila,” Cell Reports 9, no. 3 (November 6, 2014): 1151-62, 
https://doi.org/10.1016/j.celrep.2014.09.044.  
54 Zhang et al., 2 quoted in Ren et al., “Enhanced Specificity and Efficiency of the CRISPR/Cas9 System 
with Optimized SgRNA Parameters in Drosophila,” 1151-62.  
55 Zhang et al., 2 paraphrased from Ren et al., 1151-62. 
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Moreover, “[d]irect delivery of [a] purified Cas9 protein and sgRNA into cells has [shown] 
to result in reduced off-target effects compared to the delivery of plasmid sequences [that] encod[e] 
Cas9 and sgRNA.”56 Plasmid sequences of Cas9 and sgRNA are the replicated sequence of the 
pure Cas9 and sgRNA. Hence, if a purified form of Cas9 and sgRNA are introduced in cells then 
the rate of off-target effects is reduced rather than using the plasmid sequence of it that contains a 
secondary version of Cas9’s and sgRNA’s sequence which are not considered to be pure. This is 
because pure Cas9-sgRNA complexes cut DNA nearly right after delivery and can disintegrate 
quickly in cells.57 The plasmids do not degrade right away like the pure complexes which means 
that they are susceptible to having off-target effects occuring.  
There are various types of scientific methods that are used to detect these off-target effects. 
These methods would be the T7 endonuclease assay I, web-based predictions and ChIP-based 
sequencing, GUIDE sequencing, HTGTS, IDLV Digenome sequencing, and FISH.58 For the 
purpose of this thesis, I will only name these methods rather than explain them because of their 
complicated scientific explanations. Some of these methods are more accurate than others. Some 
of these methods could detect mutations at a lower frequency and others at higher frequencies.59  
In summary, CRISPR-Cas9 is known to cause off-target effects in genes which can be an 
issue if one is trying to treat a disease. There are still improvements that need to be made regarding 
these off-target effects and scientists are using different methods to detect these effects in order to 
help reduce them. 
 
4) How Gene Enhancement Coincides with Gene Therapy  
The CRISPR-Cas9 technology can be used to for gene therapy, which is used to cure or 
treat illnesses, but it can also be used to enhance certain genetic traits. In addition, there could be 
different possibilities of how gene therapy and gene enhancement coincide and share some 
commonality.  
It is possible that some gene-editing interventions that are made to treat patients with 
serious illnesses could also have enhancement effects when given to healthy individuals.60 For 
example, a therapeutic genetic intervention for muscular dystrophy could also strengthen muscles 
in healthy a person.61 Genetic interventions that treat health issues by enhancing genetic 
 
56 Zhang et al., 3, quoted from S. Kim et al., “Highly Efficient RNA-Guided Genome Editing in Human Cells 
via Delivery of Purified Cas9 Ribonucleoproteins,” Genome Research 24, no. 6 (April 2, 2014): 1012-19, 
https://doi.org/10.1101/gr.171322.113; S. Ramakrishna et al., “Gene Disruption by Cell-Penetrating Peptide-Mediated 
Delivery of Cas9 Protein and Guide RNA,” Genome Research 24, no. 6 (April 2, 2014): 1020-27, 
https://doi.org/10.1101/gr.171264.113.  
57 Zhang et al., 3, paraphrased from Kim et al., “Highly Efficient RNA-guided Genome Editing in Human 
Cells via Delivery of Purified Cas9 Ribonucleoproteins,” 1012-1019; Ramakrishna et al., “Gene Disruption by Cell-
Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA,” 1020-27. 
58 Zhang et al., 4-5.  
59 Zhang et al., 4-5. 
60 Eric T. Juengst, “Crowdsourcing the Moral Limits of Human Gene Editing?” Hastings Center Report 47, 
no. 3 (May 2017): 19, https://doi.org/10.1002/hast.701.  
61 Eric T. Juengst, “Crowdsourcing the Moral Limits of Human Gene Editing?” 19, paraphrased from 
National Academies of Sciences, Engineering, and Medicine, Human Genome Editing: Science, Ethics, and 
Governance (Washington: National Academies Press, 2017): 116, https://doi.org/10.17226/24623.  
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components “that restore functionality or resist functional deterioration might be of interest to 
enhancement engineers.”62 
Another way a therapeutic intervention can also be seen as a genetic enhancement is 
through the modification of pathological traits.63 These therapeutic interventions would be related 
to cognitive illnesses. Something like this “is also not implausible, as interest in early detection 
and prevention of late-onset diseases fosters the discovery of new clinical entities like ‘mild 
cognitive impairment’ as targets for medical intervention.”64 Therapeutic interventions could 
become very important in early detection of cognitive disorders in order to prevent it and also treat 
it as well. Furthermore, society in the future could have a different view on what the accepted 
normal range for certain traits are, and genetic improvements are able to give catch patients up to 
speed with the “new normal.”65 Therefore, when society decides what the normal traits of the 
average person are supposed to be then improvements using therapeutic interventions to help 
patients catch up will no longer be seen as genetic enhancements.66 
 
5) The Science of Mitochondrial Replacement 
One alternative to the gene editing technology CRISPR-Cas9 is another gene editing 
related technology called mitochondrial replacement. This technique is considered to be somewhat 
safer compared to CRISPR-Cas9 because it is only the mother’s heritable traits that are passed 
down and not the father’s. For CRISPR-Cas9, the offspring would obtain both their mother and 
father’s heritable traits. Germline genome editing via CRISPR-Cas9 is more disconcerting than 
mitochondrial replacement techniques since mitochondrial DNA carries a lesser amount of genetic 
material than genomic DNA.67 Therefore, mitochondrial replacement techniques could be 
considered safer than CRISPR-Cas9. In addition, mitochondria have a smaller amount of genes 
and these genes have their own specific roles to play in that organelle.68 Hence, the chances of this 
technique going wrong are quite low and there is no nuclease-based engineering (CRISPR-Cas9) 
that is occurring, meaning no off-target or unintended mutations.69 For CRISPR-Cas9, there are 
still some off-target mutations that occur when trying to do gene therapy to treat a disease. There 
have been improvements on this, but with CRISPR-Cas9 it is still likely that these off-target 
mutations could occur. Furthermore, the harmful effects that are transplanted in the mitochondria 
cannot be passed down through sexual reproduction like the nuclear genome because the 
mitochondria are inherited only through the mother.70  
Moreover, a harmful genetic mutation that arises across all mitochondrial genomes in a 
body is called “homeoplasmy” or there is “heteroplasmy” which is when harmful genetic 
 
62 Juengst, 19. 
63 Juengst, 19. 
64 Juengst, 19, paraphrased from Peter J. Whitehouse and Eric T. Juengst, “Antiaging Medicine and Mild 
Cognitive Impairment: Practice and Policy Issues for Geriatrics,” Journal of the American Geriatrics Society 53, no. 
8 (August 2005): 1417-22, https://doi.org/10.1111/j.1532-5415.2005.53411.x.  
65 Juengst, 20. 
66 Juengst, 20. 
67 Katrine S Bosley et al., “CRISPR Germline Engineering-the Community Speaks,” Nature 
Biotechnology 33, no. 5 (May 2015): 485, https://doi.org/10.1038/nbt.3227.  
68 Bosley et al., “CRISPR Germline Engineering-the Community Speaks,” 485. 
69 Bosley, et al., 485. 
70 Bosley et al., 485. 
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mutations arise in some mitochondria.71 Mothers who are homeoplasmic will pass that mutation 
to their offspring and offspring from heteroplasmic mothers will inherit both mutated and healthy 
mitochondria.72  
The first mitochondrial replacement technique is maternal spindle transfer (MST) which 
helps to get eggs from the mother and a donor.73 The eggs from the mother have the mutant 
mitochondria while and the donor’s eggs do not.74 Next, the chromosomes which are in the spindle 
shaped group of both eggs are taken out and the mother’s chromosomes are transferred to the donor 
egg who had its own nucleus removed.75 The reconstructed egg now contains healthy mitochondria 
and can be used for in vitro fertilization.76 Thus, the healthy mitochondria can now be passed down 
through the mother to future generations and there will be no risk of getting a mitochondrial 
disease.77 Additionally, if the chromosomes that were transferred do not carry enough harmful 
mitochondria that cause heteroplasmy, then the future child will live a healthy life.78 
The next mitochondrial replacement technique to be discussed is protonuclear transfer 
(PNT) which is when two zygotes are fabricated in vitro, where one of them is created with the 
parents’ sperm and egg then another with a donor egg and the father’s sperm.79 In PNT, the father’s 
sperm is used, whereas in MST it is only the female egg. During the first couple of hours, when 
the sperm has fertilized the egg, the germ cells of both parents/donors are bound to two different 
cell membranes that are called the male and female ‘pronuclei’.80 Both pronuclei are taken out 
 
 71 César Palacios-González, “Ethics of Mitochondrial Replacement Techniques: A Habermasian 
Perspective,” Bioethics 31, no. 1 (December 14, 2016): 29, https://doi.org/10.1111/bioe.12307 ; paraphrased from 
Nuffield Council on Bioethics, Novel Techniques for the Prevention of Mitochondrial DNA Disorders: an Ethical 
Review (London: The Medical Research Council, the Nuffield Foundation, and the Wellcome Trust, 2012), vii, 
https://www.nuffieldbioethics.org/publications/mitochondrial-dna .  
72 Palacios-González, “Ethics of Mitochondrial Replacement Techniques: A Habermasian Perspective,” 29, 
paraphrased from Nuffield Council on Bioethics, Novel Techniques for the Prevention of Mitochondrial DNA 
Disorders: An Ethical Review, vii. 
73 Palacios-González, 29, paraphrased from Nuffield Council on Bioethics, vii; Masahito Tachibana et al., 
“Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells,” Nature 461, no. 7262 (August 
26, 2009): 367-72, https://doi.org/10.1038/nature08368 ; Louise A. Hyslop et al., “Towards Clinical Application of 
Pronuclear Transfer to Prevent Mitochondrial DNA Disease,” Nature 534, no. 7607 (June 16, 2016): 383-86, 
https://doi.org/10.1038/nature18303 ; Mitsutoshi Yamada et al., “Genetic Drift Can Compromise Mitochondrial 
Replacement by Nuclear Transfer in Human Oocytes,” Cell Stem Cell 18, no. 6 (June 2, 2016): 749-54, 
https://doi.org/10.1016/j.stem.2016.04.001.  
74 Palacios-González, 29-30, paraphrased from Nuffield Council on Bioethics, vii; Tachibana et al., 
“Mitochondrial Gene Replacement in Primate Offspring and Embryonic Stem Cells,” 367–72; Hyslop et al.,, 
“Towards Clinical Application of Pronuclear Transfer to Prevent Mitochondrial DNA Disease,” 383–86; Yamada et 
al., “Genetic Drift Can Compromise Mitochondrial Replacement by Nuclear Transfer in Human Oocytes,” 749-54. 
75 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Tachibana et al., 367–72; 
Hyslop et al., 383–86; Yamada et al., 749-54 
76 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Tachibana et al., 367–72; 
Hyslop et al., 83–86; Yamada et al., 749-54. 
77 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Tachibana et al., 367–72; 
Hyslop et al., 383–86; Yamada et al., 749-54 
78 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Tachibana et al., 367–72; 
Hyslop et al., 383–86; Yamada et al., 749-54. 
79 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Lyndsey Craven et al., 
“Pronuclear Transfer in Human Embryos to Prevent Transmission of Mitochondrial DNA Disease,” Nature 465, no. 
7294 (April 14, 2010): 82-85, https://doi.org/10.1038/nature08958.  
80 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Craven et al., “Pronuclear 
Transfer in Human Embryos to Prevent Transmission of Mitochondrial DNA Disease,” 82–85. 
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from both zygotes on the first day of their development before they fuse together.81 Moving on, 
the parents’ pronuclei are moved to the enucleated (no nucleus) zygote, which was made with the 
donor’s egg and then the reconstructed cell is transferred into the uterus.82 The other pronuclei and 
the enucleated zygote made with the mother’s egg are thrown away.83 If the chromosomes that 
were transferred do not carry harmful mitochondria that can cause a disease, the future child will 
live a healthy life.84 Therefore, if the future child is heteroplasmic then this means the child will 
have a mix of healthy and mutant mitochondria.85 To sum up, MST uses the egg whereas PNT uses 
the sperm. Both these methods try to remove disease causing mitochondria as best as possible to 
ensure that a healthy baby is born. 
 
Conclusion 
In summary, CRISPR contains two components: the cutting enzyme Cas9 and the guide 
RNA. We first need to identify which genetic sequence needs to be genetically edited.86 Then, 
CRISPR-Cas9 functions to make a cut in the DNA at the precise location where you want to insert 
and replace the DNA.87  
The science of CRISPR-Cas9 works in a variety of ways, whether it is to edit a gene to 
eliminate a disease or to enhance a genetic trait. Still, there needs to be extensive work done to 
decrease unintended mutations caused by the off-target effects. Once research starts improving, 
CRISPR could become a powerful tool in the world of medical science. Overall, the science of 
CRISPR-Cas9 can help a person better understand how this technology works and why it is 
becoming so popular in society today. By knowing the science behind it, it will help with ethical 
and theological perspectives in the chapters that follow. Since we now know about what goes on 
in our bodies with the CRISPR technology, it helps us think about the different ethical and 




81 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Craven et al., 82–85. 
82 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Craven et al., 82–85. 
83 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Craven et al., 82–85. 
84 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Craven et al., 82–85. 
85 Palacios-González, 30, paraphrased from Nuffield Council on Bioethics, vii; Craven et al., 82–85. 
86 “CRISPR explained,” Mayo Clinic, July 24, 2018, YouTube video, 1:38, 
https://www.youtube.com/watch?v=UKbrwPL3wXE.  
87 Rachel Haurwitz, “CRISPR: Editing our genetic instructions | Rachel Haurwitz | TEDxSanFrancisco,” 
TEDx Talks, October 26, 2016, Youtube video, 15:41, https://www.youtube.com/watch?v=wktwXGAbP_Q.  
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Chapter 2: Ethics and Genetic Editing Technology  
 
Introduction 
For nearly thirty years, genetic engineering has been a subject of interest in relation to 
ethics, first starting with prenatal genetic testing, then the mapping of the human genome, and now 
more recently, gene editing with CRISPR-Cas9. There has been a growing concern about scientists 
meddling with human genes because of the rapid development in genetic sciences over the years. 
More specifically, ethical questions arise about making changes to a person’s DNA, such as editing 
a person’s DNA in order to prevent disease or even enhance a genetic trait.  
A question can be raised concerning the moral agency of a person such as, is a person still 
in control of their autonomy if their genetic traits are chosen for them? Moreover, is one 
responsible for their actions once they become genetically modified? For instance, will a person 
feel that they are in control of their actions or would they feel that a third-party is in control since 
the changes were made by someone else? Some individuals say that the person in question is fully 
responsible for their actions because that person is able to choose whether or not they want to use 
the enhanced capacity that was given to them. A genetically modified person is autonomous and 
able to make their own choices when it comes to their bodies just like a non-enhanced person. 
Another concern is that gene editing could trigger a new difference in classes of people, such as a 
superior race and an inferior race. The superior race would be those who can afford to be 
genetically modified, whereas those who cannot would be considered inferior. As a result, this split 
could create social issues such as segregation. People tend to be more in favour of gene therapy 
when done on somatic genes, since it could help prevent diseases. Edited genes on the human 
germline are still a topic of discussion since these changes will be passed down from one 
generation to the next. This brings up the question of consent; how could people who are not born 
yet consent to this? Some say it would not be right to change the human germline considering that 
those future generations cannot approve it, but others say consent would not matter since this 
change will be for the greater good. Gene editing raises many ethical questions.  
Jürgen Habermas is one of the best-known scholars to speak about this subject because of 
his book, The Future of Human Nature, where he specifically states that he is against genetic 
modifications. He believes parents should not intervene because the unborn child is not able to 
give consent.88 Habermas also asserts that enhanced children are “made rather than grown,” 
meaning that these children will be genetically modified for certain traits rather than achieving 
them naturally through their life experiences as they grow up.89 In this chapter, I will explore these 
ethical questions by first discussing the argument Habermas makes regarding gene editing which 
will then pave the way for the second section, which is the intervention of parents in the genetic 
makeup of their children. In the third section, I will be drawing on Peter Herissone-Kelly’s article 
“Habermas, Human Agency, and Human Genetic Enhancement: The Grown, the Made, and 
Responsibility for Actions,” to elucidate John Harris and Michael Sandel’s positions on how gene 
editing affects autonomy. In the fourth section, I will discuss moral agency and responsibility in 
relation to the actions of a genetically modified individual. Next, I will consider how prenatal 
genetic interventions could disrupt the natality of an unborn child and how environmental causes 
can also disrupt this. Natality is the very condition of being born where a person is still able to be 
 
88 Jürgen Habermas, The Future of Human Nature (Cambridge: Polity, 2003), 51. 
89 Habermas, The Future of Human Nature, 53. 
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autonomous despite societal influences. We will see how Habermas contradicts himself on this 
notion in regards to his exception on therapeutic interventions and how environmental factors can 
influence a baby in utero. In the sixth section, there is the question of psychology, that is, can a 
person be autonomously conscious after being genetically modified? Are they able to understand 
that they still have control over their autonomy? The seventh section will discuss how gene editing 
could cause an eradication of different animal species which could lead to extinction. The final 
section will touch upon how gene editing could cause social superiority since a select population 
could be able to access it.  
 
1) Habermas’ Argument 
Jürgen Habermas has important insights in relation to genetic modifications. Ethicists and 
philosophers always mention his statements when it comes to explaining their own views on 
genetic interventions and generally either support or oppose them. Habermas’ philosophical 
arguments on this topic come from his book, The Future of Human Nature. 
Habermas believed “that genetic manipulation could change the self-understanding of [a] 
species in [a] [very] fundamental way[,] [where] the attack on modern conceptions of law and 
morality [could] affect the inalienable normative foundations of societal integration.”90 Thus, for 
Habermas, an individual’s perspective of themselves is changed dramatically when using genetic 
interventions. These new perspectives that people may have of themselves could affect the law and 
morality of society by allowing for these enhancements to happen or to even give special treatment 
to those who are enhanced. This could cause a problematic division within society.  
Moreover, Habermas discusses whether or not parental intervention in the genetic makeup 
of their child is the correct thing to do. He says that “the parents’ choice of a genetic program for 
their child is associated with intentions [that] will later take on the form of expectations addressed 
to the child.”91 When it comes to parental intervention, it may seem that they do have good 
intentions for their future children and want the best for them, but these intentions turn into 
expectations once the child grows up. They expect their child to follow the life plan that they 
bestowed upon them by editing a certain trait in them. For instance, they enhanced the child’s 
intelligence so that they could become a medical doctor. Thus, they expect the child to use their 
enhanced intelligence and strive for the goal that the parents wanted. In their decision making, 
parents were only looking at their own preferences, as if they were speaking about an object.92  
When the children grow older, they will start seeing themselves differently because of these 
changes their parents made. For instance, when the adolescent learns about the plan that was drawn 
up by their parents for intervening in their genetic makeup in order to modify specific traits, the 
perception of being “grown” may be replaced.93 Also, when questioning their self-perception, they 
could see themselves as something “made.”94 When a person is grown, they experience life 
naturally and with contingency learning through experience about their likes and dislikes. When a 
person is made, it means that someone chooses genetic qualities for them that they expect them to 
 
90 Habermas, 26. 
91 Habermas, 51. 
92 Habermas, 51. 
93 Habermas, 53. 
94 Habermas, 53. 
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use in the future. These qualities were made for them and did not grow from the self that was given 
to them at birth. They may no longer feel responsible for their actions because they feel they were 
a product of someone else’s desires. The requirements for the moral self-understanding of 
autonomous actors are jeopardized.95 The relationship between the person who intervened and the 
subject in question is formed in a way where the subject feels that the person who wanted them 
genetically enhanced is responsible for all their actions. The subject loses the natural human 
precondition, which is to understand themselves as autonomous actors and as their own decision 
makers. 
It can be said that Habermas’ view on genetic interventions is a negative one; he is 
completely opposed to it. He believes that individuals will lose their autonomy and contingency 
when genetically enhanced. Yet, he states that a parent or third party can only consent to the 
exception that the genetic intervention may prevent “extreme and highly generalized evils.”96 Still, 
what diseases would classify as extreme and evil since each disease is harmful in their own way? 
 
2) The Intervention of Parents 
Parents always want what is best for their children and sometimes that means intervening 
with their genetic makeup in order for them to live a healthy and overall good life. Furthermore, 
individuals “conduct [their] lives in ways that are valuable to [them] and that protect [their] 
descendants against the harmful vagaries of fate as [much] as possible, where responsibility is 
attached to those ventures.”97 For example, a deadly inherited disease. In addition, these 
individuals, who could also be parents, feel that it is in their responsibility to be protective from 
anything that could be bad.  
Even if prenatal genetic interventions are not used, future descendants will not remain the 
kinds of beings they are now because evolutionary forces will cause change at some point in time.98 
In Timothy F. Murphy’s article, “In Defense of Prenatal Interventions,” he states that, “if we want 
[our] human descendants to stay human in the contemporary sense, we would have to intervene 
[…] with [prenatal genetic interventions] to protect against these [evolutionary] changes, and make 
sure those interventions reach […] [future generations] that [could] drift into [different] beings.”99 
These genetic changes would need to be inserted in the human germline, so that future generations 
do not go through any evolutionary changes. John Harris, a bioethicist, stated that “[w]hether or 
not nonhuman persons arise through technology or, in the course of further Darwinian evolution, 
in the future, the far future perhaps, there will be no more humans.”100 This means that even 
without the use of gene editing technologies, a nonhuman species could emerge naturally. Again, 
we do not know the agenda for human evanescence but in biogenetic terms , there is no escape 
from change.101 Therefore, even though we do not know the timeframe for the change of the human 
 
95 Habermas, 63. 
96 Habermas, 63. 
97 Timothy F. Murphy, “In Defense of Prenatal Genetic Interventions,” Bioethics 28, no. 7 (October 1, 2012): 
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species, there is no stopping it because nature is always evolving, even long before the invention 
of gene editing technologies. With this in mind, Murphy believes that if individuals attempt to hold 
on to the biogenetic species that we currently are, they would have to do genetic interventions that 
involve authorships of another person’s life.102  
One would need to analyze what ‘an extremely and highly generalized evil’ is in 
accordance to the problems human beings encounter every day.103 For instance, for genetic reasons 
some people are immune to HIV infections while most are not.104 Habermas’ theory of morality is 
not violated according to these differential outcomes because it was by chance and all people need 
to be considered morally equal in order to author their lives in the right way.105 Murphy states that 
“all the benefits that prenatal genetic interventions could confer in terms of resistance to disease 
[…] [fail] to undermine Habermas’ objection to parents’ authorships of their children’s lives, 
because on his analysis the benefit of protecting against HIV infection would not outweigh the 
importance of preserving the conditions of moral equality.”106 Habermas’ objection will still stand 
even if a diseases can be prevented for future offspring. The natural lottery falls under his theory 
of morality where a life of chance will dominate because Habermas does not believe in a fixed life 
history that genetic interventions provide.  
In order to treat matters consistently, the level of acceptability for prenatal genetic 
interventions seems to be any illness or disability that undercuts the prospect for the authorship of 
a life, not situations that introduce some kind of evil into human life.107 Hence, it seems plausible 
to think that the greatest evils that happen to human beings are those of great pain and suffering, 
but it may not diminish the ability to author a life.108 Yet, this questions Habermas’ exception 
because not all pain can alter a person’s autonomy. In fact, it can make a person contemplate their 
suffering so that they can figure out what they should do in that situation. For instance, a person 
could be involved in a bad accident leaving them paralyzed from the waist down, but still 
competent to make their own decisions about how they want to live their life since they were not 
left incompetent. Likewise, unless these types of individuals are greatly incapacitated by their pain, 
people can still maintain the ability to make decisions about how to live with it.109  
When a person is incompetent mentally, they cannot make decisions about how to live 
through their mental illnesses. In addition, “some genetic disorders do undercut the prospect of 
self-authorship (without involving extreme physical pain and suffering) significantly since they 
disable the very conditions of choice and it is presumably for that reason that the use of [prenatal 
genetic interventions] would be morally acceptable […] because of the [indirect] pain and 
suffering that [being mentally incompetent may involve].”110 The use of prenatal genetic 
interventions to aid in a child's brain development would be morally acceptable for the child 
because they could regain a sense of autonomy. When a child is born with a mental or cognitive 
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defect, they are not able to make their own choices rather it is their caregiver who does that for 
them. Therefore, they might not be autonomous agents. The child with the defect may not be aware 
of the pain related to not being able to make their own choices but the people around them are. For 
this reason, prenatal genetic interventions could be morally acceptable since the child could have 
a chance at being cognizant and autonomous. This could help parents who have down-syndrome 
children, although they can still retain a certain amount of their mental capacity, therapeutic 
interventions may help them regain their full autonomy. Moreover, if therapeutic interventions are 
used, this could lower abortion rates for parents who use prenatal genetic testing to see if their 
child will have a severe mental illness since their likely to terminate the pregnancy because of 
those illnesses. 
Furthermore, it seems fair to argue that parents should be allowed to intervene prenatally 
in their children’s genetic traits to the point that foreseeable outcomes can interfere with the ability 
for a person to author a morally good life.111 For instance, some cognitive disorders, although not 
that extreme, can interfere with the ability for individuals to implement choice in their lives.112 
Cognitive disorders are a great example of how one’s autonomy is impaired since they do not have 
the capacity to even think thoroughly. Ultimately, they are not the authors of their own lives. In 
addition, to have that freedom taken away because of a disease can be extremely upsetting and if 
therapeutic interventions can help with this, then it may be beneficial for the future. 
In Murphy’s article “In Defense of Prenatal Genetic Interventions,” he draws on John 
Rawls’ veil-of-ignorance methodology to demonstrate how it is possible to reject Habermas’ 
concern about the threats that genetic interventions may pose to the equality of human beings.113 
John Rawls suggests that individuals sit behind a veil-of-ignorance which keeps them from 
knowing their identity and identifying with their own personal situations in order to come to a 
judgement about what one ought to do.114 When we are ignorant towards our own situation, we 
can objectively consider how societies function without any biases.115 There are two principles 
that are included in Rawls’ veil-of-ignorance method. The first one is the liberty principle, which 
confirms that every person enjoys the maximum liberty possible without interfering on anyone 
else’s freedom.116 The second one is the difference principle, which states that if there are any 
social or economic differences in a social setting, then one should help the less fortunate and any 
advantages should be available to all of society regardless of social class.117 Essentially, a veil-of-
ignorance allows one to put aside any personal circumstances in order to see if a specific objective 
could benefit a community.  
The veil-of-ignorance method challenges Habermas’ main objection about genetic 
interventions. It requires decision makers to identify certain standards that measure the morality 
of different social practices.118 This means they put their own identities aside, contemplate how it 
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would affect all populations and what they ought to do.119 This is a method decision makers will 
use to see if Habermas’ objections can be dismissed. Therefore, if genetic interventions were 
evaluated through the lens of a veil-of-ignorance methodology, “the use of [genetic interventions] 
[might] not violate the conditions that Habermas says are [important] to moral equality because 
contingency is preserved relative to the fate of the decision makers.”120 This means that every 
person oversees their own life and contingency depends on our human choices because each person 
is the author of their own life whether they are genetically modified or not. In addition, since their 
decisions have to abide with protecting all possible selves, decision makers under a veil-of-
ignorance make decisions for the sake of all humanity and how it would benefit all populations.121  
Children whose parents have used prenatal genetic interventions will have a contingent life 
just like any other child who is not the product of prenatal genetic interventions. If a parent has the 
power to choose the sex of the child regardless if it is from sperm-sort mechanisms, dietary 
practices, folk practices, or prenatal genetic diagnosis, they do not interfere with the child’s 
capacity to live as a being with a sex.122 Therefore, the sex selection of a child will not interfere 
with the outcomes of this person’s life since they will be able to make any choices regardless of 
what sex they are. Even though their sex was chosen for them, this does not mean that these 
children must live their lives a certain way or as a specific gender. Each child has the option to 
choose the life they want to live regardless of what gender they may be. 
 
3) Harris, Sandel and Autonomy  
John Harris, a prominent pro-enhancement bioethicist, states that Habermas’ book, The 
Future of Human Nature, is “excruciatingly complex,” “crushingly conservative,” and he accuses 
Habermas of “mystical sermonizing.”123 For Harris, there are other parental factors that influence 
a person’s life history besides genetic enhancement. He states that “[o]ur parents and teachers 
[who] shape our education, make choices about our diet, encourage the development of [certain] 
talents, bring us up with certain values, and so on.”124 These influences have an immeasurable 
effect on a person’s life history where the choices that parents and teachers make are wise ones 
and are not seen as unethical.125 Harris states that “if such influences are destructive [to] autonomy, 
then there has never existed any autonomy to destroy [since] there has never been a human being 
free of such influence.”126 People will always want to look up to someone that inspires them and 
want to improve themselves so that they can be like them.  
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Michael Sandel opposes human genetic enhancement, yet rejects Habermas’ claim about 
the impact of human agency and autonomy.127 Like Harris, he believes, “our lives are already 
irreversibly and profoundly influenced by the decisions of others without any apparent diminution 
of autonomy.”128 Sandel concentrates on Habermas’ claim that it is crucial for human beings to 
view themselves as “grown” rather than “made.”129 This part of Habermas’ work is compatible 
with Sandel in two ways.130 First, Sandel claims that one of the most important things in human 
life is the quality he calls “giftedness,” which is significant because it will contain a reasonable 
amount of “openness to the unbidden” and “a correlative relinquishment of a drive toward mastery 
and domination.”131 Sandel’s concept of giftedness relates to having contingency in human life 
and that a person should be exposed to things that are in a way, unplanned. Which goes hand in 
hand with the fact that some individuals will give up on certain skills that they wanted to master 
because this is how life works. We try to learn something and sometimes we fail so we move on 
to something else and see if it works for us. It is by chance that we learn something new to see if 
we pass or fail it. Second, since giftedness is important to any human life, then “it points beyond 
the limits of liberal, or ‘postmetaphysical’ considerations.”132 Habermas stated that if individuals 
want to be free, in a postmetaphysical age, to follow their own impression of the good, the only 
thing that stops them from doing so is human genetic enhancement since it will undermine their 
autonomy in this quest.133 Since Sandel does not agree with Habermas’ claim that autonomy is 
diminished with human genetic enhancement, he believes that this giftedness goes beyond these 
postmetaphysical conditions Habermas speaks of, because these people have their own autonomy 
and are able to pursue the good in their own respective ways. They are able to make their own 
decisions on how they want to live their life. 
Let’s imagine a person has an enhanced capacity that allows them to complete the Times 
crossword in five minutes, in that moment they may be responsible for that action of completing 
the crossword where they alone decide to use that capacity.134 Peter Herissone-Kelly believes that 
“once the crossword is completed, there is another sense in which [that person] is not responsible 
for its having been finished so quickly […] [it could be] an alien capacity [that] is responsible.”135 
Consequently, a person could have the capacity to finish this crossword quickly and is responsible 
for that action but once finished, there comes a realization that maybe they are not responsible for 
it being done that fast. This external capacity is alien to them because the capacity is made instead 
of grown.136 
Since the enhanced capacity does not grow out of a given self which comes naturally, its 
presence will be viewed as discontinuous for the given self we are responsible for.137 An enhanced 
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capacity is not grown from birth, so it does not come from the given self. This means it is 
experienced as discontinuous because we are not responsible for it and it is not conceived naturally. 
Furthermore, taking responsibility for the given self, identifying that the given self and its 
capacities is how we are.138 As a result, we cannot switch our loyalty to a characteristic whose 
foundation is foreign to the given self.139 The self and its capacities are who we are, from the start 
of our lives as infants, and we grow to discover what capacities are for us that will then shape our 
identity. For this reason, to switch to a new capacity that is outside of our given selves is 
unacceptable.  
Peter Herissone-Kelly asserts that the issue of autonomy is always questioned when it 
comes to genetic enhancement and feels that there is something undesirable about it and is not sure 
it could ever be justified.140 This is because Habermas’ claim about enhancement procedures 
having a negative impact on an enhanced person’s autonomy is referenced more to cases about 
first-person, self-sanctioned gene editing.141 Herissone-Kelly thinks that Habermas’ claims on the 
negative aspects of genetic enhancement will work better on self-sanctioned enhancement rather 
than the third-party/parental enhancement scenarios he refers too in The Future of Human 
Nature.142  
Herissone-Kelly goes on to say that Habermas’ central message is that genetically enhanced 
humans would have a feeling of diminishment in regards to their autonomy because of being 
enhanced and being unable to feel responsible for the lives they would live.143  
He wants to justify the claim on whether or not enhancement has an impact on human 
agency since Habermas only speaks of third-party/parental enhancement, meaning consent is 
assumed by a parent and not consent that the patient in question gave himself or herself.144 For 
instance, enhancer A conducts genetic enhancements on an embryo that will become person B and 
A prevents B from being the author of their own life by making A that author.145 Thus, the person 
conducting the enhancement procedure on the future person will be the author of that person, where 
that offspring will not be an autonomous agent. Herissone-Kelly feels this reasoning is not correct 
for two reasons.146 First, it seems to rely on an inaccurate and weak genetic determinism that 
assumes that once a genotype is put in place there is a predestined life history.147 An edit to one 
specific gene which then makes a person’s life history predestined seems to be an unreasonable 
statement since that person is still able to do many other things in their life. Second, an enhanced 
person will be genetically enhanced for specific characteristics, not globally.148 To be more 
specific, an embryo is genetically enhanced to be athletically gifted and this could have a great 
influence on their life.149 However, it would not govern their whole life history, nor would it guide 
 
138 Herissone-Kelly, 207. 
139 Herissone-Kelly, 207. 
140 Herissone-Kelly, 201. 
141 Herissone-Kelly, 201. 
142 Herissone-Kelly, 201. 
143 Herissone-Kelly, 202. 
144 Herissone-Kelly, 202. 
145 Herissone-Kelly, 202. 
146 Herissone-Kelly, 202. 
147 Herissone-Kelly, 202. 
148 Herissone-Kelly, 202. 
149 Herissone-Kelly, 202 
22 
 
them to want to acquire those athletic abilities.150 It is possible for an enhanced genetic trait to 
have a great impact on a person’s life, but a person is still able to lead a life they want and make 
the choice on whether or not they want to develop that specific enhanced trait.  
Peter Herissone-Kelly asks two questions in the case of self-sanctioned enhancement: one 
is “How is it that I can be responsible for actions that proceed from capacities that are simply 
given, capacities that I did not choose?”151 He answers that we take responsibility for a given self 
which makes us responsible for our actions so why can we not take responsibility for the attributes 
of the enhanced self, enhanced capacities that we chose and actions that come from them?152 
Therefore, the choice of an unenhanced person to enhance themselves is a choice that must come 
from a given self for which they are responsible.153 However, the enhanced capacity does not 
flourish from the given self because it is not something the given self has the capacity for, it is 
alien to it.154  
Herissone-Kelly’s second question states: “How is it that I can only be responsible for such 
actions?155 Why would I not be responsible for actions that proceed from a capacity that I had 
wholly chosen?”156 And yet, with this question, we can see that the person could have doubts about 
whether they are the only ones responsible for their actions. The appearance of an enhanced 
capacity could be viewed as discontinuous with the self for which we are responsible.157 This 
means that an enhanced capacity would have an alien effect on the self, something that is not 
familiar. Even if it is something for which we take responsibility, it is still not something that was 
grown. 
 
4) Moral Agency and the Responsibility for Actions  
 Genetic modifications can change a person genetically by either preventing disease or by 
enhancing traits, but could it really change the autonomy of a person? This introduces moral 
agency which is the condition of the possibility of responsibility for our actions and our ability to 
act in the world.158 Is a person still responsible for their actions after being genetically modified? 
Peter Herissone-Kelly believes “[g]enetic modifications undercut that agency and therefore our 
responsibility for the resulting actions that, in a sense, happen to us rather than being the effects of 
choice.”159 Herissone-Kelly also states that “[one] can only look at that outcome as an event 
external to oneself: ‘because [an] enhanced capacity does not grow out of [our] given self…its 
presence will be experienced as discontinuous with the self for which we have taken 
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responsibility.’ ”160 It is clear that Herissone-Kelly believes that a person loses moral agency once 
genetically modified and that it is external to the person’s given self which is from birth.  
Timothy F. Murphy objects to what Herissone-Kelly says about moral agency diminishing 
when genetic modifications are introduced. For instance, parents may want to introduce prenatal 
genetic modifications that enhance athletic abilities, but they are aware that these modifications 
would not determine the person’s entire life history since the affected person might choose another 
life path.161 Herissone-Kelly states “an example of making all the genetic modifications […] 
necessary to [give] ‘the full range of capacities responsible for high quality philosophical 
work.’”162 Even though this person would have thorough connections between genetic 
modifications and behaviour, the aspect of being able to do high quality philosophical work needs 
to be mastered by a certain amount of work and analytic skills, which are separate from genetic 
modifications.163 Genetic modifications cannot coax anyone as philosophically inclined.164 This 
means “that outcomes do not flow from capacities in any causally determinate way, certainly not 
without contextual influence [and] […] [t]here is plenty of room for the exercise of moral 
agency.”165 This goes back to the example John Harris had stated about teachers having an 
influence on an individual’s life history by encouraging the development of certain talents.166 This 
is what philosophy professors do in order for their students to become skilled philosophers. An 
edit in a gene does not make you a philosopher, rather it is about learning from people who have 
had experience in this field who can then influence you to be a great philosopher one day.  
For the case of prenatal genetic interventions, Murphy mentions that Herissone-Kelly 
claims that parents might only see the effects of genetic interventions as an deterioration of a 
child’s agency.167 Since these genetic interventions are done before a baby is born, the child is not 
aware of what changes are made and just goes about their life, whereas, the parents know about 
the genetic modifications and think their child’s moral agency is lost. Context can impact 
behaviour with methods that can defy genetic reductionism.168 The contingency of the human 
person and the choices this human person makes during life preserves moral agency.169 Not only 
does context influence behaviour that could be different from the genetic modifications that were 
given to that child but the possibility of experience and choices during their life preserves their 
moral agency. Therefore, “people who choose genetic modifications for themselves will have just 
as much contingency in their lives as would be the case as if they had no modifications.”170 For 
example, a person may want to enhance their musical abilities later on in life, but it is not for music 
competitions, but to be able to offer music lessons to children as a way to earn some money.171 
Here it can be seen that the person who chose to be genetically modified to have enhanced musical 
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abilities followed a different path in order to help others and they were responsible for this choice. 
Their moral agency is preserved through the choices they make even though they are genetically 
modified. Murphy does not see how these results, as valuable as they are, can be understood as 
morally valueless because they were accomplished through genetic modification.172 Outcomes 
from genetically modified individuals are still valuable and there is no reason why they should not 
be seen that way just because it was done with the help of gene editing.  
Likewise, one could set their personal and social goals even higher for any enhanced 
capacity that was done by genetic modification,.173 A person’s personal or social goal can be 
widened thanks to the help of genetic modification because these interventions can expand on 
choices that a person can make. For instance, one can have the ability to learn a new language and 
not only will they grasp that language faster than the average person, but they may be able to set 
their goals higher, such as to learn Portuguese or Latin.174 Hence, we have choices in relation to 
our individual capacities.175 A person may have a genetic enhancement to learn a specific language 
but that would not limit them in wanting to learn another language because a person can make 
their own choices when it comes to their own capacities. At the same time, it is not that evident 
that genetically modified people are to interpret their achievements as external to their own 
identities.176 A person’s language capacity changes over time, they learn more and more each year 
that passes, and their skills evolve. When their skills evolve, they may want a new challenge such 
as learning another language. 
Moreover, Murphy notes how Herissone-Kelly states “that the conferral of genetic 
immunity on oneself would mean that HIV protection would have been achieved as if it were an 
event external to oneself.”177 And yet, wouldn’t some health protection be preferable? Murphy 
mentions how he would prefer to have permanent immunity against HIV or any other illness rather 
than having to be medically vigilant all his life.178 A genetic intervention that could give a person 
immunity to HIV is still seen as an event external to the self of that person, but the majority would 
rather be immune to this disease than have to constantly be vigilant all their life so they would not 
contract this infection. If there comes a time where HIV can be eradicated for good using CRISPR, 
most probably the majority of individuals will choose this rather than having periodic medical 
exams. 
 
5) How Natality is Affected by Gene Editing 
 A parent who chooses to do prenatal genetic interventions on their baby is arguably 
disrupting the child’s natality. What Habermas means by natality is the very condition of being 
born, he draws on Hannah Arendt’s concept of natality, which is our being born.179 Natality allows 
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one to find themselves prior to the determining influence of socialization.180 Thus, autonomy is 
possible even with the forces of socialization.181 According to Jonathan Pugh, Habermas says “that 
influencing a child prior to the point of natality will disrupt its sense of self-continuity, since it will 
be unable to conceive of itself as ever existing in [the concepts] from the forces of socialization, 
[i.e. life’s experiences in a social setting].”182 If the population of genetically modified babies 
increases, then this specific population will have their traits pre-selected for them. This means that 
there will be less individuals actually learning and experiencing what talents they possess within 
the concepts of socializations such as educational institutions, place of employment or influential 
people. 
However, enhancement supporters are likely to point out that Habermas’ notion on natality 
seems to be in tension with his views on the genetic treatment/enhancement distinction.183 He 
claimed that therapeutic modifications are morally acceptable since a person has a right to consent 
in order to eliminate an extreme evil.184 Yet, “the claim that therapeutic modifications are morally 
permissible seems to be in tension with his appeal to natality [because] carrying out therapeutic 
modifications threatens the [conviction] that natality marks a point of differentiation of one’s social 
and natural fates just as much as enhancement modifications.”185 In both those cases, the 
contingencies of the child’s genetic makeup, which is needed for the child’s autonomy according 
to Habermas, is withdrawn.186 Modifying the genes for therapeutic purposes still alters a person’s 
genetic makeup like enhancement modifications. Therapeutic purposes go against Habermas’ view 
because the child will automatically be immune to a certain disease or infection and that child will 
be different from the unmodified children who will have a possibility of developing a certain 
sickness. If a sense of self-continuity and autonomy are needed for the contingency of a person’s 
genome, then this implies that a child who has received a therapeutic genetic intervention cannot 
have a genome that is contingent, meaning they do not have that sense of self-continuity that is 
essential for autonomy.187  
Habermas should have stated that a child who is exposed to therapeutic interventions can 
also regard themselves in a way that can justify autonomy since their therapeutic modifications do 
not contain any values that could be required for the ‘uncontaminated’ prenatal self.188 However, 
enhancement supporters could see this as problematic if they believe health itself is a value.189 
They might point out that health is a value that we mold according to the socializing influences 
that Habermas claims would threaten the future child’s notion of themselves as an autonomous 
agent.190 For example, parents would want to genetically modify a child to ‘cure’ the child’s 
deafness, but in more recent cases it was suggested that deaf parents would not consider the 
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eradication of a child’s deafness as a treatment method since they do not regard it as an affliction.191 
They would simply want them to have a good life.192 Non-deaf parents would not want their child 
to be deaf so that they could have a good life and be able to hear growing up and deaf parents do 
not see deafness as an issue because it can be an easy thing to live with. If the deaf parents were 
to genetically edit their child’s deafness, it would be for efficiency reasons and not health reasons.  
Genetic enhancement supporters might raise concerns about the argument from natality 
when considering Habermas’ claim “that a child’s ability to conceive of themselves as an 
[autonomous] agent is undermined if their parents seek to enhance them prenatally.”193 There is a 
problem with this because we are already exposed to environmental factors before natality, such 
as “our developmental well-being in utero which depends on our mother’s diet and overall 
health.”194 Moreover, in utero fetuses can be stimulated by environmental factors like playing 
specific music that can benefit the child.195 In addition, it is “not believed that these 
[environmental] interventions are [harmful] to the child’s ability to conceive of themselves as the 
author of their own life.”196 If only a specific amount of traits are useful for an expansive range of 
life plans, then enhancing these traits would not mean a prenatal expectation of a life plan.197 
Genetic enhancement can be useful to a child because they are able to choose different life plans 
they like where they will not be limited to just one as Habermas stated. Genetic enhancements 
such as the environmental factors can promote child development. Consequently, presumed 
consent for the enhancement of general purposes does not mean an expectation of a specific life 
plan and are unlikely to lead to harsh cases that are useful to any life plan.198  
 
6) Autonomously Conscious?  
Daniel C. Henrich, an ethicist, explains Habermas’ concept of ‘human nature’ as follows: 
“the term ‘human nature’ relates to those features of an individual they have developed entirely on 
their own and that have only been intervened upon under the condition of anticipated consent.”199 
Despite the fact that genetic engineering implies a reification, why should our morality depend on 
such intervention?200 Morality should not be dependent on an intervention because a person is their 
own being and can also make their own choices, modified or unmodified. 
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 On account of genetic manipulation, the individual lacks “a mental precondition for coping 
with moral expectations to take the sole responsibility for his or her own life.”201 Moreover, 
Henrich states that human nature “can be understood as a precondition of our ethical self-
understanding” and that “‘our consciousness of autonomy’ is a psychological condition for moral 
agency.”202 He also states that only some genetically modified individuals would feel unsure in 
regards to their moral accountability and that the ethical assessment of genetic engineering would 
vary from person to person depending on their psychological nature.203 Some genetically modified 
individuals will not have the psychological strength to grasp the fact that they were genetically 
edited or responsible for their actions. These individuals could lack support from their loved ones 
either because they do not see them as autonomous agents who are responsible for themselves or 
because they are not there to talk to them about their issues. It is important for the genetically 
modified individual to have a support group for their mental health because they can be there to 
help and encourage the patient that they are their own person. The support group can be there to 
reassure the person that they are responsible for their actions and not a third-party. This can 
drastically help their mental health and help them live a good life. 
Henrich mentions how John Dupré, a philosopher, states that the idea that human beings’ 
concrete intentions and life plans could be seen as a ‘genocentric fallacy’ because saying that genes 
are responsible for specific traits is scientifically wrong.204 According to John Dupré,  
It is still very common to hear references to ‘genes for’ this or that eye 
color, intelligence, height, homosexuality, and so on. However, it is vital 
to remember that though the production of particular proteins is 
necessary for the appearance of many traits, it is almost never close to 
sufficient.205  
With this is in mind, it is not enough to say that a specific gene causes a specific trait.  
Similarly, there are limits of these alien determinations that need to be mentioned. Alan 
Handyside, a genetic scientist states:  
The first is that the genetic elements that make up a trait [needs] to be 
present in one or both parents. The second is that since [IVF] results 
in only a handful of fertilized embryos for biopsy and testing, the 
chances of one embryo inheriting the right combination of genetic 
elements to [get] the desired [trait] may be too low to even make the 
procedure worth trying. Finally, although complex traits such as 
intelligence are known to have a strong genetic component, [while] 
many other variables would make it impossible to identify individual 
embryos with desired traits.206  
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Therefore, with Alan Handyside’s three reasons we can see that the process of genetic 
modifications are not as easy as they are claimed by some to be and that there are limits, which 
many are unaware of. 
 
7) Destroying a Species with Gene Drives 
CRISPR-Cas9 is being used more frequently in labs across the world. CRISPR is currently 
being used to modify insects, animals, plants, and microorganisms and to make human 
therapeutics.207 CRISPR has been used to edit the female mosquito so that it is unable to carry 
malaria and others aim to make male mosquitoes sterile to prevent reproduction or limit of their 
progeny’s lifespan.208 At the extreme, this could eradicate an entire species and could have many 
environmental consequences because of it.209  
In addition to editing a gene, there is something called a gene drive: it is a tool that makes 
it more possible to pass down an edited trait to progeny through sexual reproduction.210 The 
resulting progeny has a fifty percent chance of inheriting the edited trait, with a gene drive it can 
copy a mutation made by CRISPR on one chromosome to its partner chromosome.211 Which 
ensures that all progeny and its future descendants will inherit the edited gene.212 If this is done 
with the example of the mosquitoes then, it could in fact lower transmission rates of dengue fever 
or malaria.213 Yet, it poses a lot of large environmental risks such as destroying an entire species, 
eliminating a food source for other kinds of species or promote an excessive amount of invasive 
pests.214 Even though there are some benefits to gene drives, the risks outweigh them since it could 
make a species extinct.  
The eradication of a species using gene drives demonstrates the negative effects that gene 
editing could have in our world. It can show how this tool can wipe out an entire species of 
mosquitoes and it is experiments like this where one needs to discuss ethics and regulations. It 
would not be right to conduct experiments like these if it means a species extinction, seeing as this 
tool should be used for species to not face extinction. Experiments like this will need to face an 
evaluation in order to see if these experiments are ethical and beneficial. It would not be right to 
use CRISPR on a species to render it sterile in order to benefit another species. This is ethically 
wrong because as stated previously, it would also eliminate a food source for other animals on the 
planet. There needs to be rules and regulations set in place in order to conduct just research. 
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8) Social Superiority 
When a new cutting-edge technology is introduced to the world, the majority of individuals 
will be curious as to what it is. Something such as CRISPR-Cas9 will definitely grasp the attention 
of a lot of individuals who will want to use it in order to edit genes to be immune to certain diseases. 
Specifically, gene therapies that affect the human germline because that will mean future offspring 
will be immune to certain diseases. Also, others may be interested in genetic enhancement in order 
to enhance some genetic traits. These desires always come at a price and not many individuals 
would be able to afford this. 
There are at least three different concerns that are raised in relation to the negative impact 
on society with genetic interventions. The first concern is wealthy people having access to genetic 
technology in order to have an advantage over the poor, both within nations and on a global 
basis.215 Could this create an increasing divide between social classes?216 Could this divide also be 
applied to poor and rich nations?217 The rich could have a higher advantage over the poor because 
they can afford these special treatments. This could cause a divide between social classes where 
the more affluent individuals will have access to this genetic technology to better themselves and 
as a result, possibly see themselves as more superior than unenhanced humans.  
The second concern is that genetic enhancement could deteriorate the respect that people 
have for one another.218 Could this lead to individuals seeing themselves as profoundly different 
from the poor?219 As mentioned previously, enhanced beings could start seeing as themselves as 
better than the unenhanced person, and this could lead to a loss of respect toward a less fortunate 
person. Some individuals could start seeing themselves as fundamentally different from the poor 
and this may lead to poor treatment of these people who cannot afford these genetic interventions.  
The third concern affects the poor because how can we explain “spending millions of 
dollars of private or federal research funds on high-tech genetics in a world where so many people 
lack access to basic medical care.”220 This will certainly have a negative impact on the poor 
because it questions how a less fortunate person could afford these genetic interventions when they 
cannot even get basic medical care in their own country. It could make the poor, poorer if this were 
to happen. 
On the contrary, “gene enhancements, if properly handled, could narrow the gap between 
society’s haves and have-nots, between developed and developing nations.”221 Thus, gene 
enhancements could offer nations things that they could have been missing in order to make their 
people healthier and stronger. Furthermore, genetic modification can challenge the superiority that 
supports class and social divisions and it can create new opportunities for the less fortunate.222 It 
could increase instead of reducing parents’ reproductive options and it could possibly avoid bad 
eugenics of the past.223 Additionally, germline gene modifications “may actually lower health care 
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costs for [people] by replacing costly halfway medical technologies with dramatic new solutions 
to health care needs.”224 Individuals will not need to spend as much money on medical exams. 
Since CRISPR can target the eradication of diseases in the somatic and human germline, then they 
will not need to get regularly checked for a certain disease they have had for themselves or for 
their future offspring. 
 
Conclusion 
The ethical debate of CRISPR-Cas9 presents many opinions on whether or not it should be 
allowed. It raises many questions regarding the outcomes when it comes to third-party 
interventions.  
Many believe that they should not be intervening because it should be up to the future child 
whether they want to be genetically enhanced. Habermas believes that when people intervene, the 
offspring will not be autonomous agents and will question their own self-understanding as they 
get older. Yet, sometimes it is acceptable for a parent to intervene because they only want what is 
best for their children and that is the case when it comes to therapeutic interventions, so the children 
and future generations can forever be immune to a specific disease. Correspondingly, when using 
John Rawls’ veil-of-ignorance method, contingency relates to human choices and humans are the 
author of their own lives whether they are genetically modified or not. Thus, under a veil-of-
ignorance, their decisions are to protect themselves from sickness which benefits all populations. 
It is also equally important to note that one may not be able to see themselves as the author of their 
own lives if their enhanced traits were chosen by someone else.  
John Harris believes there are other external factors that can influence a person’s life 
history, such as parents and teachers, and not just gene enhancements. No human has ever lived 
without some sort of external influence. On the other hand, Michael Sandel opposes enhancement 
not because of the lack of life history claim, where one has their life predetermined because of a 
specific trait that was chosen for them, but because people will not be exposed to chance to see 
what they are good at and not good at. Yet, a person could still be fully autonomous and responsible 
for their actions despite being genetically enhanced. An enhanced person still has the power to 
decide on whether or not they would want to use their enhanced capacity even though it was given 
to them by someone else. Their moral agency and autonomy will not be diminished, and they will 
have just as much contingency as the unenhanced person. Likewise, some say they would want 
their children to be immune to certain diseases instead of having them be cautious all their lives in 
order to avoid contracting them. With these reasons in mind, it is important to note the 
psychological effects of an enhanced person where sometimes that enhanced person cannot 
mentally grasp the fact that they are responsible for their own actions rather they think someone 
else is. This is why they would need a support group to reassure them that they are their own 
person. Like the unenhanced person, we all handle our situations differently.  
Additionally, some say the role of gene editing could eradicate a species which could lead 
them to extinction. This can be seen with the example of mosquitoes where they are genetically 
edited to be sterile in order to not carry malaria and give it to humans. This shows the negative 
aspect of gene editing without any regulation. Then there is also the aspect of social superiority 
where genetically modified individuals will be superior over those who are not because they cannot 
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afford this kind of treatment. These less fortunate people will not be respected as equals anymore. 
On the other hand, gene editing could help the less fortunate by giving them more reproductive 
options and replace the medical care we have currently with more cutting-edge technology.  
Ultimately, the ethics of gene editing allows for many questions to be asked and each 
situation needs to be assessed accordingly to determine if it is something that could be beneficial 




Chapter 3: Theology and Genetic Editing Technology  
 
Introduction 
With CRISPR-Cas9 emerging in the scientific world and all the contemporary ethical 
issues surrounding it, it is important to evaluate it in terms of a deeper meaning, specifically 
through a theological perspective.  
In the science and medical world, it is important for physicians to treat their patients 
exceptionally well. The foundations of Christian faith provide an understanding of what this 
means. Daniel Sulmasy, a general internal medicine doctor and bioethicist, insists that when 
healing a patient, it should be done as an act of love. Sulmasy states that through the love a 
physician has for God, they should do everything they possibly can to save the patient, who is 
incarnate in God, until there are no other means left. In Christian faith, God created humanity in 
his image, thus God is incarnate in them. This means that doctors are to serve patients who want 
to be treated so that they can improve themselves in the image of God and doctors must do this 
with love to preserve God’s work on Earth. In addition, he also states the importance of a 
physician-patient relationship by drawing on Franciscan compassion which means to go above and 
beyond for the patient in imagining new ways to help treat their illness. Sulmasy also emphasizes 
the importance of transcendent questions that a patient may have and how a doctor should go about 
addressing them.  
Genetic modification also raises the issue of humans trying to play God. Papal and church 
documents from Popes John Paul II, Benedict XVI, and Francis have mentioned that the risks 
associated with germline gene editing are too grave to even attempt but somatic gene editing is 
acceptable. It is strongly suggested in these documents that there needs to be a discussion to 
regulate these genetic interventions.225 Furthermore, according to the Jewish and Christian 
tradition, when God created humanity, humans were not equal to God and should not be second 
guessing God’s will or doing anything to his creations when they are not ill, such as genetic 
interventions to enhance a trait. Genetic modification draws the attention of future-oriented 
theology, meaning we look forward to future offspring as being a part of our community and how 
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the future people adapt to change. This theology envisions a future that God may have intended, 
where humanity will preach God’s divine purpose for a life with reduced pain and suffering. 
Genetic enhancement can be seen as a type of salvation because it helps escape human 
error, but this is not the true form of Christian transcendence. In terms of the Christian doctrine of 
eschatology, every human and non-human creature is on its way to its unity and glorification in 
Christ. However, some say that technology could tempt humanity to imagine a future made by 
human effort relying on something other than God’s grace. Genetic modification raises the 
question of what it means to be human. Humans can be changed by genetic modifications but 
according to some, that does not mean God will see them as any different from non-modified 
humans. Some say it is a way to improve what God has made. The answer to what it means to be 
human brings different viewpoints where scholars may not be in agreement with each other. 
From a Jewish perspective,226 it is important for a doctor to heal a patient because they are 
God’s agent and genetic modification can be seen as a health care option to heal all. God created 
the world in a way for humanity to constantly improve in order to preserve God’s creation and this 
is what genetic modification can do.  
This chapter discusses the importance of Christian faith in healthcare (in the section titled 
“Foundations”) and how the role of “playing God” in humans can be a problem concerning gene 
editing in relation to church documents and creation theology (the section titled “Playing God”). 
Next, in the section titled “The Jewish Tradition and Genetic Modification,” the Jewish perspective 
will be discussed exploring the Jewish view on genetic modification. Then in the section titled 
“Future–Oriented Theology,” I will discuss theology in terms of how future generations will adapt 
in our community due to the changes offered by gene editing and how it pushes individuals to 
build a life free from pain and suffering. Following this, eschatology and genetic modifications 
will be explained in order to explore how genetically modified individuals might find salvation in 
Christ. Finally, raising the question of what it means to be human will be discussed to show what 
happens when our bodies are genetically modified.  
 
1) Foundations  
The theological method of foundations is concerned with the origins, the genesis, the 
present state, the possible developments and adaptations of the categories in which Christians 
understand themselves, communicate with one another, and preach the gospel to all nations.227 It 
plays a very important role in the area of healthcare. The foundation of Christian faith is important 
in healthcare because it radically changes how the physician works. Thus, from this perspective, 
to be able to serve God is to be able to form deeper connections through spirituality, to be able to 
comfort the patient and tend to their needs through the inspiration of God’s love.  
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Love is the central ethic in Christian faith and physicians draw on love to do their work. 
Sulmasy states:  
Gospel-centered health care begins where the gospel begins, in an encounter 
with a Person. We meet that person in each patient that a physician serves, 
one at a time. Gospel faith tells us that God is love. Love is ultimately an act 
of surrender, surrender to our heart’s deepest desire, which is both of God 
and For God. The Gospel impels us to serve our patients with love, full of 
faith that the infinite God is, incarnate in our world, especially in the sick.228  
Thus, for Sulmasy, the Gospel begins with an encounter with a Person (God) and it introduces the 
global aspect of what God is, which is love. The Gospel sheds light on how doctors can serve 
patients with love because God is incarnate in our world, specifically in people who are ill. To 
rephrase Sulmasy’s words, love is the ultimate surrender to our heart’s deepest desire which is both 
of God and for God. We should serve each patient as if we were serving God, which will make the 
physician provide the best care they possibly can.  
What light might this shed on the physician/patient relationship in genetic modification? 
For many, in the Christian faith God created humans in his image which means God is incarnate 
in them. This suggests that doctors serve these patients who want to improve themselves in the 
image of God with the utmost love to preserve God’s work on Earth. In a secular society, can 
Christian values be altered to some degree where individuals see love as something to satisfy their 
own desires?229 They can disregard agape, the other-regarding love, which Christian faith 
considers to be the highest form of love and which is also God’s love for humanity.230 Some doctors 
who focus on the advances of science rather than the well being of their patients, can demonstrate 
a selfish love instead of a love they have for God. Since CRISPR is a relatively new technology, 
the physicians who have had breakthroughs with CRISPR might see it as a sense of 
accomplishment, which could symbolize a self-satisfying love, rather than the love that they have 
for their patient.  
Sulmasy also mentions that transcendence plays an important role when wanting to 
incorporate the foundation of Christian faith in healthcare. Physicians are to heal whole persons; 
not only to understand injury to the body but what disease and injury can do to them as an embodied 
spiritual person dealing with transcendent questions.231 Here it can be seen that physicians need to 
be able to heal people by understanding that the illness affects the body and spirit because this 
person could have numerous deep questions about their illness. Moreover, if physicians “are to 
heal patients as whole persons, they themselves must seriously engage in transcendent questions 
that only persons can ask” and if they are “true healers, they must rediscover what it means for 
health care to be a spiritual practice.”232 They can rediscover the meaning of spirituality in 
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healthcare by engaging in the patients’ questions and a bond can be formed. Furthermore, illness 
raises troubling questions of a transcendent nature, about meaning and value. How physicians 
address these questions for themselves will affect the way they help their patients struggling with 
them.233  
Transcendent questions of meaning that can arise from patients are: “what is the meaning 
of my illness?” “…my suffering?” “…my death?”234 When it comes to disease, patients wonder 
what illness means and what the meaning of suffering is, which will then lead to questions 
concerning their death. The physician might help the patient reflect on what it means, if there is 
something one might hope for even if that patient is not cured, or if there is any spiritual 
significance to the word ‘hope’.235 This could imply that hope could be religiously related or it 
could signify a prayer that needs to be expressed.  
Transcendent questions about value are questions patients have concerning how value 
relates to their appearance, to their productivity or their independence.236 In addition, these 
questions ask if there is anything about that patient that is valuable when their appearance, 
productivity or independence are threatened.237 These questions also ask if there is anything 
valuable about the patient that will persist after death.238 Physicians may also have questions 
regarding value such as if the patient is able to hold on to a sense of their own dignity and 
purpose.239 Do the people close to the patient care about them as a person?240 Are there any spiritual 
or religious resources upon which the patient can draw to help see them through this?241  
The transcendent healing process of the divine is not only found in dying patients but in all 
moments of the hospital experience since they are always communicating meaning and value to 
patients.242 Physicians are always communicating transcendence to all patients because they care 
about their patients’ well being and want to be able to help their patients spiritually. Sometimes a 
physician-patient relationship can be shattered, for instance, when a physician uses a drug 
incompetently and they violate the trust the patient has placed in them.243 A good healthcare 
professional will address the patient’s questions as to why this drug was used incompetently in 
order to try and rebuild the patient’s trust once more. It is a trust that transcends the relationship 
between the patient and physician and transcends the pharmaceutical drug.244 To betray that trust 
is to deny the spirit.245  
We have argued that transcendent questions that a patient asks a doctor are very important 
in a physician-patient relationship. Sulmasy’s insights can also be used in relationships scientists 
can have with patients in terms of gene editing. These patients will also have questions regarding 
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meaning and value in relation to what happens after the gene editing process is completed. When 
a doctor is using gene therapy on a patient, they need to understand that the disease not only affects 
the body but also the spirit. Before going through with these gene therapies, physicians will need 
to engage in transcendent questions in order to understand their patients. This will then indicate 
that they are forming deeper connections with their patients rather then just a quick fix using 
genetic interventions. 
Gene therapies play a part in the process of transcendent questions of meaning. The patient 
will want more information in regards to the disease they have and how the cure could fix it. They 
want to know why there is so much suffering from the disease they have and about the possibility 
of death. The doctor then explains to them more about their specific disease and the chances of 
them being cured after taking part in these genetic interventions. In regards to the death aspect, the 
doctor can mention the possibility that they will be able to live a long and healthy life after 
receiving this treatment. Therefore, the doctor gives the patient hope and could also refer them to 
a spiritual coordinator if they wish to receive help beyond the medical world. 
Transcendent questions about value also play an important role in the world of genetic 
modifications. This is where the patient could be struggling the most yet also receive a sense of 
purpose again. With the aid of genetic therapy, a person’s value can become positive since the 
disease can be treated and they may start feeling better physically. They may then be able to live a 
productive life and act independently and make their own decisions. With the help of gene therapy, 
patients may begin to see themselves as valuable because they may be able to contribute to society. 
It might be possible when death approaches them in old age, that they can look back and see that 
they did live a valuable life that their loved ones will remember. A spiritual coordinator could speak 
with a patient to see if they are able to understand their own dignity and purpose after being 
genetically edited. Spiritual coordinators can do this by asking questions such as “are you 
concerned you will not be the same person?” or “do you feel you are not responsible for your own 
actions anymore?” Some people may not be able to grasp the fact that their genetic makeup has 
been edited. Specifically, if it was a choice done by a parent and the child only finds out later in 
life. This might cause that person to feel that they are not responsible for their own health but rather 
someone else is. The physician also needs to make sure that the people close to a genetically 
modified patient still sees them as a person and not someone who is alien to them. The physician 
should consult with the family and see if they have any questions regarding the genetic 
modification process. The physician could address their questions and reassure them that the 
patient is still the same person they knew prior to the procedure. If the family still has further 
questions that the physician is not equipped to address, they can refer the family to a therapist who 
can better aid them in speaking about their feelings with this. Furthermore, if the patient is 
struggling to grasp this new change then the physician may recommend a spiritual/religious or 
psychological resource in order to help them gain a sense of themselves.  
For individuals that have a terminal illness and cannot be cured by gene therapies, 
traditional Christian theology still considers their lives as valuable. These patients may have lived 
with this illness through the course of their life and were dependent on others, but it does not mean 
that their lives were not worthwhile. They were valuable in the sense that they belonged to a family 
or had people that they loved. Terminally ill or not, Christian ethics sees human lives as valuable.  
Since Sulmasy was a Franciscan friar, he explains the importance of compassion in 
Franciscan spirituality when incorporating it in the foundation of Christian faith in healthcare in 
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three different forms. Sulmasy explains the difference between generic compassion and Franciscan 
compassion.246 Franciscan compassion is mediated along the following three dimensions; 
personal, incarnational and imaginative.247 In terms of genetic modification, only incarnational and 
imaginative will be considered because personal has already been mentioned above. 
The second dimension of Franciscan compassion is incarnate compassion. Incarnate 
compassion means compassionate action.248 For instance, it means emptying bedpans, using 
morphine judiciously to relieve the pain of the dying patient, binding wounds with reverence and 
love, and taking the time to listen.249 Consequently, physicians who live and practise a Franciscan 
spiritual life will be present in the flesh.250 These listed examples demonstrate that compassionate 
action is about being attentive to the patient’s needs and giving them the best possible care. It is 
about being there for them. In addition, it means to go the extra mile to fight for the needs of 
patients when they are denied essential care such as health insurance by societies that transform 
healthcare into a business exchange.251 In other words, it is a physician's job to provide health care 
to all patients. In a story with Saint Francis and Saint Clare, they showed concern for their sick 
brothers and sisters by feeding them grapes, providing feather pillows and blankets to help with 
their discomfort252 Saint Francis and Saint Clare first demonstrated this compassionate action in a 
simple way by feeding and providing comfort to the sick which then sets an excellent example for 
physicians acting in today’s secular world.  
The third dimension of Franciscan compassion is imaginative compassion. Physicians with 
Franciscan imagination will see in the suffering of patients and in the suffering of the physician, 
the suffering of Christ the Lord.253 Physicians who practise Franciscan spirituality should have 
imaginative compassion in order to imagine Jesus’ suffering in themselves and in the patients they 
treat. Moreover, physicians put their hands in bloody wounds every day and need to have religious 
imagination to find God there because God is in the suffering and in the compassionate hand that 
reaches out to heal.254 Physicians are to treat the wounds of the patients as if they were treating the 
wounds of God.  
Furthermore, Franciscan imagination encourages scientific research for the sake of the 
sick.255 God’s gifts of reason and imagination seek new ways to ameliorate the symptoms of 
suffering.256 Franciscan imagination will also challenge physicians to create new healthcare 
structures because healthcare today increasingly dulls the imagination, turning patient care into an 
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assembly line.257 The Franciscan approach personalizes the healthcare system, creating doctor-
patient relationships based on love rather than a business model. 
This is an important factor for scientists to consider with their patients who want to use 
genetic interventions and want to form a virtuous relationship to them. To have a doctor who listens 
to you and tends to your needs when you are ill is essential because a trusted bond is formed 
between the physician and patient. These doctors/scientists know that gene therapies can be costly 
and not everyone can afford it. For this reason, it should be up to doctors to stand up for patients 
when the government and insurance companies deny this essential care to patients who need this 
treatment. This would not be fair because every person has the right to essential health care. As 
stated in the previous chapter, gene editing technologies could replace our present mediocre 
technologies in order to give society the proper health treatments they need. 
The third dimension of Franciscan compassion also plays an important role in terms of 
genetic modification. It gives the scientists/doctors a mental visual as to what the patient is going 
through and what their suffering must feel like with the illness that they have. The symbolism used 
to imagine Jesus’ suffering in patients can drive scientific research for the sick, for instance, the 
use of genetic interventions with CRISPR. This type of motivation will only have an impact on 
scientists/doctors who are believers in Christ. Through God’s gifts of reason and imagination, 
scientists will conduct more research to see how CRISPR can target the infected DNA. This will 
prompt scientists to conduct research on animals to test its accuracy and see what off-target effects 
could occur. Through these continuous tests, improvements can be made to reduce the off-target 
mutations. Once that has been done, scientists and doctors can move on to conduct human clinical 
trials in order to see its effect on humans and if the disease is treated permanently.  
Physician-Patient relationships that draw on Christian spirituality could provide important 
insights for scientist-patient relationship in gene editing. The insights of Christian spirituality 
exemplified in Franciscan compassion can be used for genetic modifications in order to help 
scientists/doctors have a deeper understanding of their patients and see them as more than test 
subjects in a lab-based experiment. 
 
2) Playing God 
Genetic modifications can give people the power to manipulate genes in order to improve 
themselves by either eradicating a disease or enhancing a specific trait. This kind of power can be 
seen as a God-like power to the human person. Individuals are able to change a human being’s 
genetic makeup prenatally either to be immune to a certain disease or even enhance a certain trait 
according to the parents’ desires. Some Christians would not agree with this because they feel that 
they are violating God’s creation since God made everyone in his image. 
Public opinion polls at the beginning of the era of genetic engineering in the early 1980s 
showed that two-thirds of Americans believed that altering human genes is against God’s will.258 
In addition, in a nationwide telephone survey that was commissioned by Harper’s Magazine in 
1997, people were asked to choose from a list about who should have the power to control the 
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genetically linked characteristics of a child before birth.259 Less than one percent of respondents 
chose “the doctor”; eleven percent chose “the parents”; sixteen percent chose “no one” and seventy 
percent chose “God”. 260 At that time, the average American was known to be quite religious and 
many felt as though only God had the power to control genetically linked characteristics. In 
January 2016, a poll was conducted by STAT and the Harvard T.H. Chan School of Public Health 
in the United States asking who should make decisions on whether or not to allow changing genes 
before birth.261 Fifty-three percent said it should be left up to scientists, physicians and similar 
experts.262 Nine percent said it should be left up to government officials and policy makers.263 It is 
clear from the 2016 poll Americans have become more secular and believe that 
scientists/physicians should be responsible for changes made on genes. Nineteen years ago, it was 
less than one percent who said it should be up to the doctor, indicating that many Americans today 
have more faith in science than in God, indicating that Americans may have come to trust science 
more but this does not necessarily mean that they have lost faith in God. 
Despite a climate of increasing secularism, the Church provides contributions to the global 
decision-making process in rapidly advancing technologies.264 The distinctive reasoning and 
values of the Catholic church offers one possible framework for achieving the goods of human 
genome editing while avoiding its harms.265 
In 2003, Cardinal Joseph Ratzinger266 openly approved germline genetic engineering that 
involves genetic modifications in a man’s sperm-producing cells, i.e. a man’s germline cells.267 
Other Christian commentators urged a special caution to it because it involves germline 
interventions.268 Yet, Ratzinger and the other commentators both agreed that interventions 
designed to prevent or cure disease, including those that can safely eliminate a genetic disorder 
from a family line, are consistent with the traditional permission for human medical care.269 The 
church document, Communion and Stewardship: Human Persons Created in the Image of God 
also stated that: 
Germ line genetic engineering with a therapeutic goal in man would in itself be 
acceptable were it not for the fact that is it is hard to imagine how this could be 
achieved without disproportionate risks especially in the first experimental stage, 
such as the huge loss of embryos and the incidence of mishaps, and without the use 
of reproductive techniques. A possible alternative would be the use of gene therapy 
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in the stem cells that produce a man’s sperm, whereby he can beget healthy 
offspring with his own seed by means of the conjugal act.270 
This statement clarifies Ratzinger’s early statement about approving germline gene editing in a 
man’s sperm. If gene therapy is used to alter the genetic makeup on a man’s stem cells to produce 
a man’s sperm, then they can conceive babies naturally rather than genetically modifying an 
embryo which poses too many risks. 
 In 2008 Benedict XVI271 who was part of a congregation that wrote the church document, 
Dignitas personae, which directly addresses gene therapy and states that “procedures used on 
somatic cells for strictly therapeutic purposes are in principle morally licit since such actions seek 
to restore the normal genetic configuration of the patient or to counter damage caused by genetic 
anomalies or those related to other pathologies” (Italics are mine).272 As for germline therapy, 
since the risks connected to any genetic manipulation are not yet fully controllable “in the present 
state of research, it is not morally permissible to act in a way that may cause possible harm to the 
resulting progeny…the questions of using genetic engineering for purposes other than medical 
treatment also calls for consideration” (Italics are mine).273 Germline gene editing is still 
something that could pose a danger to future generations even if it is to cure a disease and 
enhancement procedures still need to be spoken about among the general population to see if it 
should be allowed. 
The commonality between the two texts show that Benedict XVI and his congregation 
agree that germline genetic engineering is not safe enough to use because of all the risks that were 
associated with it. More research needs to be done in order for it to be effective. The only plausible 
option would be somatic gene therapy since it is the safer option or gene therapy on a man’s sperm 
using stem cells. Anything that involves changes to future generations should not be considered 
just yet. 
John Paul II stated that “a curative intervention, whether genetic or otherwise, generally 
‘falls within the logic of the Christian moral tradition.’”274 Furthermore, in John Paul II’s apostolic 
letter Dolentium hominum, he states “that medicine and therapeutic cures be directed not only to 
the good and the health of the body, but to the person as such who, in his body, is stricken by 
evil.”275 Healing the person does not only mean healing the wound, it includes the healing of the 
spirit as well. When a person is healed spiritually, their positivity and will for life come back. Evil 
is not only the disease, but also how the disease affects the person spiritually. For instance, the 
disease could lead the patient into a depression. Thus, when a doctor restores the patient back to 
health, they are removing this depression as well and the patient’s morale improves. The concern 
about playing God seems to focus on the idea of genetic enhancement. John Paul II articulated his 
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opinion by stating that he approved of medical genetic interventions but “he urged the avoidance 
of ‘manipulations tending to modify the [human] genetic store.’ ”276 
In Francis’ encyclical letter Laudato si’, he states on the topic of genetic enhancement that 
“discussions are needed in which all those directly or indirectly effected (farmers, consumers, civil 
authorities, scientists, seed producers, people living near fumigated fields, and others) can make 
known their problems and concerns, and have access to adequate and reliable information in order 
to make decisions for the common good, present and future.”277 With gene editing, there needs to 
be a discussion, not just with scientists, but everyone because this is something that will affect all 
of humanity. While Francis is referring to genetically modified food, his comment can be applied 
to examples related to therapeutic interventions. There needs to be a discussion on what illnesses 
should be considered for its use. This would involve scientists, doctors, patients, patients’ families 
and government. By going through different case studies, government and medical professionals 
would need to come together to decide what diseases qualify for genetic therapy. Yet, every illness 
is harmful and severe in its own way and government officials need to take this into consideration. 
Patients and their families need to be involved in the discussion to advocate their views that they 
should be allowed to use gene therapies regardless of what illness it is. The government needs to 
listen to what they have to say and make decisions around that as well. This is why discussion is 
important; it allows all the voices to be heard and understood. There needs to be discussion and 
regulation in order to make decisions that will benefit us presently and for the future. 
The use of genetic modification for purposes other than medicine also needs to be 
discussed. For instance, in Dignitas personae it states that: 
Some have imagined the possibility of using techniques of genetic 
engineering to introduce alterations with the presumed aim [to] [improve] 
and [strengthen] the gene pool, [but] these proposals exhibit a certain 
dissatisfaction with or even rejection of the value of the human being as a 
finite creature and person. Apart from technical difficulties and the real and 
the potential risks involved, such manipulation would promote a eugenic 
mentality and would lead to social stigma with regard to [certain] people 
who lack certain qualities, while privileging qualities that happen to be 
appreciated by a certain culture or society.278  
Therapeutic modifications to the germline might not be completely ruled out if safe procedures 
and outcomes can be achieved.279 Clinical trials are still required in order for therapeutic 
modification to be approved completely. The risk of off-target effects are too hazardous to even 
attempt on the human germ line since subsequent generations could be affected. Moreover, to 
purposely create people who are considered better and more valuable than others raises a 
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disagreement in the assessment of different human beings which violates the Christian vision of 
primacy of the equality of all human lives.280  
In the book of Genesis, God repeatedly states that creation, including the creation of human 
beings, to be “good” or “very good” (Genesis 1:4, 10, 12, 18, 25, 31).281 In a world created by God 
as “good”, do we have the authority to make changes or improvements?282 The world came into 
existence with divine blessing, and to change it, other than to repair the damage that humans 
brought, can be seen as a rejection of God’s sovereignty and trying to play God.283 Some Christians 
hold the view that a human person should not be God-like and change the world God made. This 
view applies to genetic enhancements because the human genome comes into being at God’s 
behest.284 Granted, the correction of disorders do fit in with the general permission to diminish the 
ravages of sin, gene enhancement exemplifies to second-guess God’s will for a child and putting 
ourselves in God’s place by attempting this technology.285 
Habermas draws on theology to explore the idea of the distinction between Creator and 
creature. He draws on Christian Theology by saying that human beings are made in the image of 
God: they are creatures and cannot be equal to God.286 Furthermore, humans were created free but 
if they were emanations from God, their being would be equivalent to God and remain determined 
by God’s being.287 However, Robert Song, an ethicist, states that since humans are created by 
God’s will, there can be a definite difference between creator and creature, and God’s 
determination of humanity can also be a determination that they are free.288 Humans are given the 
Bible to understand God’s guidelines, but it is their choice to understand what is right and wrong. 
God gave humanity the gift of free will and choice. Guided by an interpretive community, human 
beings can choose what they want to do with the information in the Bible. Accordingly, it is a 
person’s choice then, whether or not they choose to apply genetic interventions on an embryo or 
be genetically modified themselves. It is their decision on whether it is right to play God in that 
sense. 
The fact that humans are created, there are three implications that are relevant to the 
question of genetic enhancement.289 First, according to Christian theology, the goodness of 
creation which includes our bodies makes a clear assumption against intervening.290 In addition, 
the Western tradition of medicine states that if the body is healthy, the first thing a doctor should 
do is to not perform any action that would harm the body.291 Since genetic enhancement procedures 
are invasive and with the potential of off-target effects then it would not be recommended. Still, 
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therapeutic interventions may be allowed but more research is needed to reduce effects that can 
harm the body. If the body is healthy, then the doctor will research to see if this intervention will 
cause more harm than good considering its side effects. The doctor should not be playing God if 
they do not need to; if the body is healthy then doctors should not do anything to it. They should 
not enhance the body that God made if there is nothing wrong with it, especially since off-target 
effects could occur, potentially causing ailments to the body.  
Secondly, even a favourable decision to intervene in an individual case has limits with 
regard to human responsibility for the future.292 The future is not something we can mould as a 
whole.293 Still, parents feel that it is their duty to make plans for the future because therapeutic 
interventions can prevent unnecessary illness. They want to guarantee that their child is born 
healthy and free of a disease that would disrupt their quality of life. On the other hand, people 
performing genetic enhancement could control the future in regards to creating a human person 
tethered to their specific needs. The future needs to occur naturally and not be known to present 
people unless it is to prevent a disease. The only time it seems plausible for a human to play God 
and mould the future is to prevent or eradicate a disease with genetic modification. This ensures a 
healthy life for the future human being. 
Thirdly, the resurrection as the confirmation of the created order also opens a discussion 
for making distinctions between therapy and enhancement, between healing what is wounded and 
enhancing what is given.294 Medicine, from a theological perspective is understood in terms of 
healing, which in the New Testament symbolizes a witness to salvation in Christ.295 Humans are 
not trying to play God in this perspective, rather the patient they are healing with therapeutic 
interventions symbolizes God, therefore it is as if they are healing God as Sulmasy mentioned in 
the previous section. He also stated that the person being healed by the physician symbolizes the 
salvific Christ who rose from the dead and it is the physician’s purpose to do everything they can 
to heal that person.296 If the patient is healed, it symbolizes the Christ who rose from the dead.297 
This is not always the case for the terminally ill, but it is the physician’s job to provide them with 
the best possible care they can. The danger of genetic enhancements is that it suggests the body is 
raw material to be improved by technology, where salvation can be seen as part of the gnostic 
struggle to escape from human frailty.298 In terms of genetic enhancement, CRISPR can be used 
on the body to edit the genes the person desires because humans feel the need to fix themselves 
since they feel they are defective or imperfect, i.e. wanting to escape from human frailty. In the 
case of genetic enhancements, humans are considered to be playing God in a sense because they 
are enhancing themselves to escape the body that God gave them. They see genetic enhancement 
as a salvation because of the improvements it does to the body instead of trusting what God has 
for them. 
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3) The Jewish Tradition and Genetic Modification 
While the focus above has been on Christian perspectives in exploring ethical and 
theological thinking around genetic modifications, there is also literature providing Jewish 
perspectives that are important to consider. Rabbi Joseph Karo, author of the Shulchan Arukh, 
which is an authoritative code of Jewish law states that a physician who does not attempt to heal a 
person when he can is considered a murderer and this concept can be applied to gene editing.299 
God controls illness and health, but the physician is God’s agent and partner in the ongoing act of 
healing: “Just as if one does not weed, fertilize, and plow, the trees will not produce fruit, and if 
fruit is produced but is not watered or fertilized, it will not live but die, so with regard to the body. 
Drugs and medicaments are the fertilizer, and the physician is the tiller of the soil.”300 This 
symbolism indicates that physicians are to look after the sick and do everything they can to treat 
them in order to preserve God’s creation on earth until it is their time to pass. 
With this view of medicine and Judaism’s sense of community, there is an important 
implication for health care, generally and with germline modification.301 The community as a 
whole has a duty to provide obligatory health care to all, including the support of research to 
overcome illness and disability.302 This duty is based on two biblical passages; “Do not stand idly 
by the blood of your brother” (Leviticus 19:16) and “Love your neighbor as yourself” (Leviticus 
19:18).303 The Talmud states that the former verse is a positive duty to come to the help of others: 
“On what basis did we know that if a man sees his fellow drowning, mauled by beasts, or attacked 
by robbers, he is bound to save him? From the verse, ‘Do not stand idly by the blood of your 
neighbor.’ ”304 Furthermore, Elliot N. Dorff explains that:  
the Talmud and Rabbi Moses ben Nahman (Nahmanide, 1194-1270) argue 
that ‘Love your neighbor as yourself’ gives an express warrant to try and to 
bring cure even when that involves the infliction of wounds through surgery 
or other risks to the patient, for everyone would (or should) prefer such risks 
to certain death. They also argue that the same verse also requires us to spend 
money to heal others if we lack the expertise.305  
In Jewish scripture, “love your neighbor as yourself” involves, not just the caring for others, but 
also the specific behaviours that express that attitude, where health care is one of them.306  
Correspondingly, research involving CRISPR to cure diseases in the human germline is 
strongly encouraged. This kind of research can provide or restore health to the extent that its cures 
 
299 Elliot N. Dorff, “Judaism and Germline Modification,” in Design and Destiny: Jewish and Christian 
Perspectives on Human Germline Modification, ed. Ronald Cole-Turner (Cambridge: MIT Press, 2008), 35, 
paraphrased from Joseph Karo, Shulhan Arukh, Yoreh De’ah (1563), 336:1, later glosses by Moses Isserles.  
300 Dorff, “Judaism and Germline Modification,” 35; quoted from Midrash Temurrah as cited in Otzar 
Midrashim, ed. J.D. Eisenstein (New York: 1915) II: 580-581; B. Avodah Zarah, 40b. 
301 Dorff, 35. 
302 Dorff, 35. 
303 Dorff, 35, Bible translation not known. 
304 Dorff, 35-36, quoted from B. Sanhedrin,73a. 
305 Dorff, 35-36, quoted from B. Sanhedrin, 84b (on the permission to inflict pain in order to heal), 73a (on 
the requirement to spend money to heal when we lack expertise); Nahmanides, Torat Ha-Adam, Sh’ar Sakkanah, 
quoted by Joseph Karo, Bet Yosef, Yoreh De’ah, 336. 
306 Dorff, 36, paraphrased from B. Gitten, 61a.  
45 
 
can be made readily available to everyone who needs them.307 In addition, funds and energy should 
be assigned to this form of research by considering the likelihood of achieving such results in 
contrast to other treatment therapies.308 Hence, if genetic interventions show positive progress, it 
is definitely something that the Jewish tradition encourages.  
Does Judaism also encourage genetic enhancement? As with the Christian community, 
genetic enhancement is not as widely accepted as therapeutic interventions. The Jewish concept of 
healing as an obligation includes the greater obligation to work toward fulfilling the Jewish 
mission of tikkun olam which means fixing the world.309 This could imply the use of genetic 
enhancement in order to improve the world we live in.  
Could fixing the world include genetics? It depends on Judaism’s understanding of 
technology.310 Adam and Eve are told in the Garden of Eden “to work it and preserve it” (Genesis 
2:15).311 God wants humanity to continuously preserve the earth. We must always be preserving 
the earth for God. The rabbis stated:  
Observe the work of God, for who can repair what he has ruined? At the time that 
the Holy One, blessed be He, created the first man, he took around and showed him 
all its trees of the Garden of Eden. He said to him: ‘Observe my creations, how 
beautiful and praiseworthy they are. Everything I created, I created for you. Take 
care not to ruin or destroy my world, for if you ruin it, there is nobody to fix it after 
you’.312  
In terms of genetic enhancement, it is clear that enhancing genes could help preserve the world 
that God made.  
God intended that humans are to steward the world that he made during their life and act 
as God’s agents to improve it.313 This was stated in a rabbinic comment about circumcision.314 The 
comment states that “if God wanted all Jewish boys circumcised, the rabbis ask, why did He not 
create them that way?”315 The rabbis’ response was that “God deliberately created the world in 
need of fixing so that humanity would have a divinely coordinated task in life, which gives the 
human life purpose and meaning.” 316 Furthermore, humanity is not just allowed, but mandated to 
find ways to bend God’s world to God’s purposes and ours as well.317 However, we must preserve 
the world God made in the process.318 Consequently, it is a human’s divine purpose to fix what 
God has made because there is always room for improvement in our world. If the world was made 
perfect, then there would be nothing for humanity to do. Genetic enhancements can help with these 
improvements. 
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The Jewish tradition allows that technology can be both good and bad depending on how 
we use it.319 If it is used to aid in the forming the world to achieve morally good ends while we 
preserve the world, then this use of technology is theologically approved and morally good.320 Yet, 
if humans neglect their duty to preserve the world through the use of technological tools, then they 
are involved in a theologically and morally bad act.321 Genetic intervention technologies are 
encouraged to be used for the greater good to preserve the world God made. 
 
4) Future-Oriented Theology 
Future-oriented theology of creation and its understanding of the human being as God’s 
created cocreator can be explained in three ways. First, a future-oriented theology of creation is 
not impeded by giving priority of existing persons over future generations.322 The theology of the 
continuing of creation looks forward to the new, for instance, individuals who do not yet exist.323 
They will exist in the moral community that humans belong to, which constantly encourages to 
improve living conditions.324 One of these improvements could be CRISPR. Through genetic 
modification, a healthy society can be achieved as well as traits improved. Moreover, abundant 
food is able to be made without it getting spoiled.  
Second, future-oriented theology is realistic in taking into account that through the course 
of time, things are subject to change.325 What individuals do affects and is affected by the future 
with their different possibilities.326 Individuals need to be creative in terms of what could be good 
and bad for the future.327 For instance, doctors and scientists are conducting more research on gene 
editing. This will follow with more clinical trials to see if the genome editing process is working 
on humans. This can specifically be done with gene therapies but done mostly on somatic genes. 
If we introduce gene editing in the human germline to cure a disease, future offspring will not be 
affected by that disease. This is something that could definitely benefit society in the future. The 
creative process behind genome editing offers good aspects and bad aspects depending on a 
person’s opinion of it. Gene therapies offer something good by eliminating disease, but gene 
enhancement is still something controversial. 
Thirdly, humanity’s task is to determine as best they can the direction of divine purpose 
and use that as an ethical guide.328 What is the future that God intends? When interpreting the 
apocalyptic symbol of the New Jerusalem where “crying and pain will be no more” (Revelation 
21:4), we can be inspired and guided toward decisions today that will affect future generations 
tomorrow.329 We are driven to make a good life where our future descendants are happy and not 
suffering. One approach could be that therapeutic interventions used on the human germ line to 
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ensure that disease is eliminated forever. A future-oriented theology could view gene editing as a 
way to promote the greatest good through the development of a healthy society.  
 
5) Eschatology and Genetic Enhancement 
To define eschatology, it is the study of end times, the return of Christ, when the rapture 
occurs, the nature of the millennium, and much more.330 The rapture is when both living and dead 
believers of Christ will ascend into heaven in order to meet Jesus Christ at the Second Coming.331 
The nature of the millennium, which is explained in the book of Revelation is that Christ will 
invoke a one thousand-year reign of the saints on Earth before the Last Judgement.332 In addition, 
it is a concept of time were there will be supernatural peace and abundance on Earth.333 Thus, 
eschatology deals with humanity’s fate when it is time for the final events of the world to occur. 
When eschatology and technology are part of a discussion, the majority of the time it is not 
something positive that is being spoken about. Some Christians will use the “heresy card” to claim 
that technology tempts us to imagine a future built by human effort, as if it were some modern 
technological Pelagianism intended to lure humanity into relying on something other than grace.334 
This is considered a form of Pelagianism because the human will is capable of choosing between 
good and evil without divine aid. Ultimately, most negative replies all come down to the same 
conclusion which is to be afraid of the consequences related to gene editing technologies.335  
Technology is constantly advancing and evolving leading to human transformation. 
According to Karl Rahner, human transformation “is not concerned with this or that man but with 
man, with mankind;” humanity is seen as an engineering project and its goal is “coolly to sketch, 
design and calculate a new, different man and then to produce him technologically in accordance 
with this plan.”336 This agrees with gene editing technology since it can change all humankind 
when it is done on the human germline. In addition, genetic enhancement can be categorized as 
wanting to design and produce a human. Rahner states that technology has made human beings 
“operable” and he does not seem bothered by this.337 Rahner also says that “according to Christian 
anthropology man really is the being who manipulates himself.”338 Thus, humankind is always 
changing whether it is naturally or technologically. Moreover, Rahner states that: 
What is new in this issue is therefore not that man is faber sui ipsius [i.e. 
maker of himself], but that this fundamental constitution of man is 
manifested historically today in a totally new way. Today for the first time 
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man’s possibility of transcendental self-manipulation irreversibly takes 
on a clear and historically categorical form.339  
Consequently, Rahner states that theology today is challenged with something different which is 
the question of man’s essence.340  
Genetic modification can create a new category of human that did not exist in the past. 
Technology can aid in making a new species. It was said that all humans are made in the image of 
God but with the introduction of genetic manipulations we are able to improve ourselves, either 
by preventing illness or enhancing traits. Hence, it seems that humans may want to be the creator 
rather than created. This questions how humans will perceive themselves. What will this new 
historical category of humanity mean? Will this new human transformation be accepted? Or will 
they perceive themselves as something non-human?  
According to Ronald Cole-Turner, eschatology sees that each creature, humans included, 
as on its way to being unified with Christ.341 Christian Theology “has no utopian plan or 
technological program.”342 There is no utopian plan for a perfect eschatology, we must trust the 
mystery of God. As for technology, it cannot replace God. Christian Eschatological faith accepts 
the invitation to see all creations as open to a transformation rooted in their future in God.343 Cole-
Turner states that eschatology is open to transformations, even genetic ones as long as creation 
still relies on God’s grace. All creatures are open to smaller transformations and Christian 
eschatological faith is open to the prospect of the technological modification of the natural world, 
including human individuals and human species.344 According to Cole-Turner, Christian faith and 
hope that are open to the ultimate future as the final consummation should be open to the near 
future as an essential change as well.345 In addition, to visualize each thing as already on its way 
to its consummation is to view it as presently open to change.346 This is because each thing is 
moving toward its consummation since humanity is constantly evolving in different aspects, 
specifically technologically or biologically.  
Moreover, it is without a doubt that humans today are different from the people of the time 
of Jesus, “we believe that we are [all] included in the scope of the incarnation.”347 Even though 
the future forms of humanity may be different, they are not excluded from being in unity with 
Christ.348 We do not envision a “partial Christ who stops redeeming when technology starts 
modifying[,] God’s plan is to gather up all things in Christ.”349 A human being is still a human 
being even if they are modified, everything around us is constantly evolving and that is a fact of 
life. God gave us the power to improve ourselves and therefore we are preserving the image of 
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God in all of humanity. Genetic modification is preserving this image by eliminating disease and 
improving the human person. 
In every age, Christians believe that “neither death, nor life, nor angels, nor rulers, nor 
things present, nor things to come…will be able to separate us from the love of God in Christ Jesus 
our Lord” (Rom 8:38-39).350 The things we cannot predict will not stop God from loving humanity 
in Jesus. Based on previous statements, humans must embrace the unknown as if God had intended 
it to be like that. Cole-Turner states that when humanity has confidence in God, they can truly be 
hopeful about the future.351  
 
6) What it Means to Be Human 
There will always be an underlying question as to what happens to the human being after 
being genetically modified. People will wonder if that person is still the same or if they are 
something different. Paul Ramsey, a Christian ethicist, appears to take on a negative attitude 
towards this, he mentions something called “species suicide” meaning that making changes to the 
human flesh is a violation of what is human, such as violating human will or freedom.352 Ramsey 
is against modifications and believes that human beings should not be treated as science 
experiments. Ramsey believes that genetically modifying a person is basically identical to 
eliminating a species because a person is killing their former self. Moreover, “the human body is 
not a tool for a given human being, Human beings are bodies.”353 With this, it would be proper to 
look at the different ideas of what it means to be human.  
Some ethicists have a more open outlook regarding the human person and what makes 
them human. James C. Peterson, a professor and ethicist, states that “God’s people will still be the 
same individuals, but in a strikingly new form.”354 This should be the case as long as they continue 
to have faith in God. In addition, “according to the Christian tradition, our current physical form 
is not required for us to be human.”355 That being said, when humans ascend into heaven their 
physical bodies are technically left behind and it is their spiritual bodies that ascend. In addition, 
current bodies are not always required to who each of us is as a person.356 Hence, because of the 
soul’s ability to go beyond the physical world, physical bodies do not define the human person. In 
order to be with God, human beings were given the ability to reach transcendence through the love 
they have for God. 
Is “human” a static concept that has already been attained or does it comprise of qualities 
that can be developed positively?357 This appears to be a continuous debate that is part of the bigger 
question of what it means to be human. Some aspects of this continuous debate are: if physical 
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bodies are to remain unchanged or if physical bodies can be subjected to improvement. Human 
beings are physical beings but that does not mean that their physical nature is to remain 
unchanged.358 It is a fact that we are physical beings, but like everything else, we change over 
time. For instance, our physical nature changes since our skin wrinkles and we age. Change is 
inevitable. Moreover, future descendants will be physically different from our current state and 
could be more human in what we value as human.359 Darwinian evolution is a fact and subsequent 
generations may look different than the current human being. Future “humans” could have a 
different genetic makeup as well. Future people might have a different definition of what a human 
is. Everything in life changes and if we decide to input our current moral values in the future, there 
is a chance that the outcome could be negative. Future people may think these values are outdated 
since it does not fit with their current world views. Naturally, things around us are subject to 
change. Our bodies can change through evolution, so what makes editing genes any different? 
In an opposing view, Ramsey states that “to intervene in human genetics is to make 
[ourselves] Lord and creator [of] future generations. Human beings are to serve human life, not 
change it.”360 Human life is not to be changed and only God has the power to make changes. 
Humanity does not have the position to improve God’s creation, “only God has the authority and 
ability to form and change [humanity].”361  
 Peterson states that for James Gustafson, a theological ethicist, “human beings are not yet 
what [they] should be[,] and [they] do indeed find [their] purpose in development.”362 Therefore, 
if there is a final form, human beings have yet to reach it. Part of a human’s purpose then is to 
constantly find ways to improve themselves and their quality of life. Gene editing is a form of 
improvement on human life because it will help eradicate disease. Additionally, genetic 
enhancement will help a person make improvements in the areas where enhanced traits are needed. 
Similarly, when considering the responsibility we have to future generations, the current physical 
state of humans is not definite.363 The human person is always changing whether it is naturally or 
scientifically through genome editing. It is in our nature to want to constantly improve and develop 
ourselves. There is a place for change because we gain a sense of what values to preserve, which 
helps us “enhance the qualities of life that give[s] [everyone] a sense of fulfillment.”364 Thus, there 
is always a place for change when it comes to being human whether it is physically or spiritually. 
These changes help people preserve what they think could be valuable to the future and/or also be 
rid of other things that might hold no value in order to enhance the quality of lives for future 
generations. The fulfilment that is received when a patient’s quality of life is improved comes from 
achieving a purpose to surpass present accomplishments. Partly, this is what being human is about: 
seeking to have a good life and letting go of what has already served us in order to reach new 
goals. This applies to gene editing since scientists are continuously researching to improve 
CRISPR in order to reduce off-target effects. Then clinical trials are conducted to see if these 
improvements are working on humans.  
 
358 Peterson, 281. 
359 Peterson, 281. 
360 Peterson, 282, quoted from Ramsey, Fabricated Man: The Ethics of Genetic Control, 88.  
361 Peterson, 282. 
362 Peterson, 283. 
363 Peterson, 283.  
364 Peterson, 283, quoted from James M. Gustafson, “Basic Ethical Issues in the Bio-Medical Fields,” 
Soundings: An Interdisciplinary Journal 53, no. 2 (Summer 1970): 178, www.jstor.org/stable/41177779.  
51 
 
The individuals who argue that genetic intervention is a part of God’s mandate for humanity 
to share in creation, redemption, and transformation of creation would see a risk not in an attitude 
of pride but of sluggishness.365 Not fulfilling the duty to turn genetic modifications into a service 
would show a strong and destructive attitude of laziness.366 For this reason, if genetic interventions 
are to be part of God’s mandate on Earth then humans cannot be sluggish about it since it is shared 
in creation, redemption and transformation of creation. It plays a part in creation since foetuses 
can be genetically modified prenatally and all genetically modified individuals can be redeemed 
in Christ. The argument is that through evolution God’s people change over time so there is no 
difference when humans make changes to themselves. This is seen as a transformation of creation 
because as stated previously, human beings will always be subjected to change whether it is 
evolutionary or with genetic interventions. Genetic interventions can transform creation into 
healthier beings and with enhanced traits to help society prosper. If we can do surgery on various 
parts of the body, we can do surgery on someone’s genes.367 Therefore, for Peterson, performing 
surgery on a human body is just as much a change as genetic interventions. Both intend to make 
changes to the human person in order to improve their quality of life.  
 
Conclusion 
The theology of gene editing technologies is still relatively new, and research is ongoing 
but what has been done presently is attracting attention. In order to better introduce CRISPR, it is 
best to see how it can be examined under the foundations of Christianity. Sulmasy believes that 
the foundation of Christian faith is important in healthcare because it changes how the physician 
works. When a physician serves God, it means that deep connections are to be formed with patients 
through spirituality. Although gene editing is lab-based there are still patients that are involved in 
the process. Thus, it is important for these patients to be treated with the same love a physician has 
for God. Transcendence is also important because you are not just healing the physical person but 
also the spiritual person. In addition, physicians would help patients with any transcendent 
questions that they could have in relation to their illness and their value as a person. Moreover, 
Sulmasy states the importance of Franciscan compassion in healthcare for physicians. Doctors 
with Franciscan compassion are to go above and beyond for their patients to acquire gene therapy. 
These doctors must also be conducting constant research on gene editing to reduce off-target 
effects.  
Furthermore, playing God becomes a vital topic in the discussion of genetic modification. 
Benedict XVI approves of somatic therapeutic interventions since it is consistent with the 
traditional permission of medical care, John Paul II agrees as well. Francis believes that there needs 
to be discussion on this topic before it can be fully accepted. Their papal and church letters state 
that therapeutic interventions are good because not only do they heal, they may also remove the 
disease permanently. Somatic therapeutic interventions are approved but germline therapeutic 
interventions still need more testing. In the case of genetic enhancement, some Christian 
commentators do not approve it and feel that it is not acceptable to be making changes to God’s 
creation. There is a difference between creator and creature because God did not make humans the 
same being as God is. God made humans to be equal and intervening genetically could disrupt this 
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equality. In terms of creation, if a body is healthy, it is not right to intervene. Likewise, the future 
should not be moulded as a whole: we cannot control creation. Enhancement on God’s creation 
cannot be seen as Christian because it is as if humans want to escape human troubles instead of 
embracing the body God gave us.  
The Jewish tradition takes on a different perspective: in terms of therapeutic interventions, 
a physician must provide health care to everyone. Accordingly, genetic therapeutic interventions 
need to be accessible to everyone. Enhancement helps to preserve and improve God’s work.  
There are three ways in which genetic modifications describe a future-oriented theology. 
The first is that a current society always looks forward to future generations to see how they will 
blend in our current society, specifically genetically modified individuals. Second, nature is 
dynamic and always changing; it allows people to be creative in order to adapt to new changes. 
Third, since nature is always changing it is our duty to establish an ethical direction in this dynamic 
world on how to live a life with minimal pain and suffering.  
Christian Eschatological faith accepts the invitation to see all creations open to a 
transformation rooted in their future with God. God’s people are constantly changing, whether 
naturally or by human aid. Christ does not stop redeeming when technology starts modifying. 
God’s plan is to gather up all creation in Christ, no matter how different. People often wonder if 
the understanding of the human being changes because of these modifications. Ramsey believes 
once a person is genetically modified, it is identical to species suicide, the end of the human race 
as we speak. On the other hand, Peterson and Gustafson state that God’s people will remain his 
people but in a new form. The physical form is not required for us to be human, specifically when 
we unite with God. If genetic modifications are to be part of God’s mandate, humans cannot be 
sluggish about it because we are obliged to continuously preserve his work. 
 Overall, the discussion between genetic modifications and theology raises a lot of 
important questions on a deeper level specifically on what happens to the human person and their 
body in the eyes of God. The subject of genetic modification is being widely discussed in the 
Judaeo-Christian world to see how this technology can affect our current society. That being said, 






In this thesis, we explored the science, ethics and theology surrounding CRISPR-Cas9 and 
genetic modification. The science chapter explained the technicalities of CRISPR-Cas9. It 
explained how CRISPR-Cas9 targets the invading DNA at the spot where you would need to add 
or remove DNA sequences. It is the nuclease enzyme Cas9 which acts as the molecular scissors to 
make that cut on a specific spot on the DNA strand. Sometimes these cuts can cause off-target 
effects where unintended mutations can occur leading to some health side effects. Scientists are 
still researching and finding ways to reduce these off-target effects.  
Chapter two explained different perspectives concerning the ethics of genetic modification 
from various individuals including John Harris, Michael Sandel and Jürgen Habermas. Habermas 
was the most studied for this thesis since most ethicists draw on him primarily because of his 
strong arguments against genetic modifications. It also examined whether individuals were still 
autonomous after genetic modification. If not, who would be responsible for their actions, the 
person or their “enhancer”? Many believe that individuals are still able to make their own choices 
regarding their enhanced trait. 
 Chapter three dealt with deeper theological questions regarding the proper use of gene 
editing technologies, specifically the use of it on the human germline. These issues were brought 
up in different papal and church documents. In addition, the status of the human person after 
genetic modification was also discussed. Specifically, how some believe that God’s work is to be 
preserved on Earth with the use of CRISPR-Cas9, while others believe we should not be changing 
God’s creation with this scientific tool. Likewise, through a Christian eschatological perspective, 
some Christians believe that these modified people cannot be in union with God, while others say 
that God accepts all creatures who have faith in him. CRISPR and genetic modifications raise a 
lot of challenging questions and it is something that needs to be thoroughly regulated.  
We explored many themes and topics in this thesis in regards to genetic modifications being 
done on human beings. The two themes that seem to be the most important on this topic is the self 
and society. These two themes become important in trying to understand genetic modifications, in 
a personal aspect and also in a more global aspect. 
When we think of the first theme: the self, we think of our own person and what happens 
to us if we were to be genetically modified. Autonomy is a central concept when speaking about 
genetic modifications. While some may wonder if a person is still able to be autonomous if their 
parents intervene in their genetic makeup, the genetically modified person is still able to be 
autonomous and make their own life choices. There is also the possibility of moral agency which 
becomes important to the self. Genetically modified individuals are still able to be responsible for 
their actions, regardless of these modifications. While autonomy and moral agency are present, the 
modified person still struggles psychologically with these possibilities. There is also the question 
of self-sanctioned enhancement that Peter Herissone-Kelly speaks about and whether or not they 
are responsible for their actions after the genetic enhancements.368 If they chose to be enhanced, 
then wouldn’t they still have responsibility over their actions? 369 Yet, this enhanced capacity is 
not something that came from the self at birth.370 The self can be a conflicting theme because the 
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person is still a person after being genetically modified but they need to find it within themselves 
to understand that they are still autonomous agents who are responsible for their actions and can 
make their own decisions. 
The second theme, society, is important to consider because people interact with others on 
a daily basis and build relationships with them. A society allows voices to be heard on certain 
topics that need to be spoken about. In addition, it also plays a part in how a genetically modified 
individual will integrate in society. We previously spoke about parents who intervene genetically 
because they have a life plan for their child, however, parental influences were always there. John 
Harris mentioned how parents and teachers shape children’s education, encourage the development 
of certain talents and bring children up with different values.371 Furthermore, there is the notion of 
natality which is our being born and the person we are before being influenced by society.372 For 
Habermas, genetic modifications would disrupt this notion.373 Still, parents can influence their 
baby in utero with music to help with its development or through a diet to keep the baby healthy.374 
We see that society offers an external influence on people every day regardless of them being 
genetically modified. Furthermore, genetic modifications could also cause a divide among society 
if this new technology is not distributed justly. This technology should not be accessible just to the 
rich but to everyone to avoid a division among social classes. This technology is to help all of 
society and not a select few.  
Ethics contributes significantly to the discussion on CRISPR and genetic modifications. 
Genetic engineering in general has been spoken about frequently in the area of bioethics. Ethics in 
terms of genetic modifications raises questions about autonomy, regulations, consent, and much 
more. In addition, the contribution of ethics allows a person to understand what both sides (for and 
against) of genetic modifications have to say. Ethics helps a person understand the reasoning of 
both sides and weigh the strength of the arguments. They may not choose a side at all; they could 
remain neutral or in the middle. Ethics helps us understand why some parts may be negative and 
why others may be positive. It shows us how the negative implications of gene editing could cause 
a lot of harm. For instance, this was seen with the risk of unintended mutations causing health side 
effects of gene editing procedures. More improvement needs to be done before it can be used for 
medicine or enhancement procedures. Moreover, the ethics of gene editing needs to be 
communicated to people since they may not be aware of it. The majority of people only know of 
the simple facts related to gene editing or its basic science. Ethics contributes by giving people 
insight into how gene editing affects a person, the people around them and society as a whole. It 
can also expand a person’s knowledge on this topic, which can help them develop an opinion on 
it. This opinion can add input to the government policies on how it could be regulated. Therefore, 
it can help build policies and rules for it so that it may be accessible one day. 
The value of an ethical analysis in relation to genetic modifications and CRISPR can be 
seen in many different ways. It demonstrates the rights and freedoms that a person has regardless 
of being modified or not. Following this, it shows that genetically modified individuals can still be 
autonomous agents of their own lives. The value of an ethical analysis also shows that certain areas 
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of gene editing requires government regulations, specifically with how it will be distributed, 
ongoing improvement to reduce off-target mutations and what people use it for. In addition, we 
see the value of how far parents go to make sure their child grows up healthy by using therapeutic 
interventions. This brings up the question of consent, where one side says it is fine for a parent to 
consent for the unborn child if it means it will eradicate a disease and the other believes that a child 
should always consent regardless of it being for therapeutic purposes or enhancement purposes. If 
this technology is used wisely then it can help improve humanity. There is also value in 
comprehending both the pro and con arguments in terms of gene editing. We get to see how both 
views share valid points on whether or not it should be done. An ethical analysis lets us see that 
there is good in this new technology, but it can only be achieved if we decrease the risks associated 
with it in order for it to truly help humanity.  
The contribution of theology towards genetic modifications is recent and current literature 
on it is quite limited. Theology allows one to go beneath the surface of ethical concepts to ask 
deeper questions against backdrop of a faith tradition. It allows us to make observations that an 
ethical analysis does not. One specific observation that we can explore with theology is the 
question of what it means to be human. Reflecting on this helps us probe the question of genetic 
modification in a multitude of ways. It allows us to wonder if the human body can be changed and 
what will happen to humans if the body is changed. We begin to think of what happens to our 
physical bodies when we are united with Christ. Do our bodies really define what it means to be 
human or is it something more? This question lets us think about the human soul a lot more. In 
Genetic Turning Points: The Ethics of Human Genetic Intervention, James Peterson points out that 
Gustafson believed human beings find their purpose in development and that our current physical 
state is not definite. Do these genetic changes really make a big difference to our bodies? Are we 
still considered to be human after these modifications? Or are we considered something else? It is 
questions like these that help us probe the very essence of what it means to be human. 
A second observation that theology explores is the question of what it means to be made in 
the image of God. This helps us probe the question of genetic modification in terms of whether it 
is right to make changes to the creation God made. Is it right for one to play God on Earth? It could 
be acceptable if it is a therapeutic intervention that could save a person’s life or eradicate a disease 
from a family line. Will giving the power of God to a human being cause a rift in our world? It is 
questions like this that make us wonder whether it is right for humans to toy with the human genetic 
store, even though this could be a breakthrough in the science and medical world. Still, God gave 
humanity the gift of free will, so it is up to us to decide where to draw the line of playing God in 
certain aspects, specifically between therapy and enhancement. Therapeutic interventions are 
slightly more accepted than enhancements, if done on somatic cells. The human germline still 
poses too much risk, so we can see where a line can be drawn. However, we see in “Judaism and 
Germline Modification,” where Dorff states that some Jewish traditions do believe in therapeutic 
interventions on both somatic and germline cells because medical professionals need to do 
anything they can to heal a person. Dorff also states that enhancement is accepted as well because 
it helps preserve God’s work on Earth. We can see here that drawing the line on genetic 
modifications can vary from religion to religion or even person to person. This is where societies 
must come together and find common ground on where one should draw the line. 
CRISPR-Cas9 and genetic modifications have been one of the most recent controversial 
topics to surface. There are many contrasting views on it and opinions on how it should be used. 
This thesis explored the opposing sides of genetic modification to come to an understanding that 
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this technology, as with every technology, will have positive and negative aspects. If this is 
something that will be used in the future then improvement is still needed to make sure it is safe 
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